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Background: Anhedonia and amotivation are substantial predictors of poor functional outcomes in people with
schizophrenia and often present a formidable barrier to returning to work or building relationships. The Tempo-
ral Experience of Pleasure Model proposes constructs which should be considered therapeutic targets for these
symptoms in schizophrenia e.g. anticipatory pleasure, memory, executive functions, motivation and behaviours
related to the activity. Recent reviews have highlighted the need for a clear evidence base to drive the develop-
ment of targeted interventions.
Objective: To review systematically the empirical evidence for each TEPmodel component and propose evidence-
based therapeutic targets for anhedonia and amotivation in schizophrenia.
Method: Following PRISMA guidelines, PubMed and PsycInfo were searched using the terms “schizophrenia” and
“anhedonia”. Studies were included if they measured anhedonia and participants had a diagnosis of schizophrenia.
The methodology, measures and main ﬁndings from each study were extracted and critically summarised for each
TEP model construct.
Results: 80 independent studies were reviewed and executive functions, emotional memory and the translation of
motivation into actions are highlighted as key deﬁcits with a strong evidence base in people with schizophrenia.
However, there are many relationships that are unclear because the empirical work is limited by over-general
tasks and measures.
Conclusions: Promising methods for research which have more ecological validity include experience sampling and
behavioural tasks assessing motivation. Speciﬁc adaptations to Cognitive Remediation Therapy, Cognitive Behav-
ioural Therapy and the utilisation of mobile technology to enhance representations and emotional memory are rec-
ommended for future development.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The ability to derive pleasure from activities is a key part of the
human experience; it has positive effects on an individual's mood and
increases motivation to engage with the world around them (Foussias
et al., 2011; Frederickson, 2001). Hence any difﬁculty engaging with
pleasurable experiences is likely to lead to reduced activity levels and
social isolation. Social withdrawal and reduced functioning have been
observed in individuals with schizophrenia, particularly those who re-
port high levels of anhedonia (Krupa and Thornton, 1986).
Anhedonia is currently deﬁned as a loss of the ability to feel pleasure
and is considered to be part of the negative symptom cluster inEdwards),
m (N. Tarrier),
. This is an open access article underschizophrenia which also includes apathy, avolition, asociality, poverty
of speech and blunted affect (Kirkpatrick et al., 2006). Anhedonia is a
stable trait in people with schizophrenia which persists independently
of changes in positive symptoms, other negative symptoms and cogni-
tive deﬁcits (Berenbaum et al., 2008). Difﬁculty experiencing pleasure
and motivational deﬁcits are the most prominent among the negative
symptoms in predicting poor functional outcomes (Foussias et al.,
2011; Loas et al., 2009; Rocca et al., 2014). In at-risk andﬁrst-episode in-
dividuals, anhedonia has been shown to be an important predictor of fu-
ture diagnosis of schizophrenia (Gelber et al., 2004; Velthorst et al.,
2009). These data support anhedonia as a key therapy target but two re-
cent reviews have concluded that the effectiveness of interventions
which have reported an outcome for negative symptoms is very limited
(Elis et al., 2013; Fusar-Poli et al., 2014). Indeed, both these reviews
highlighted the lack of an evidence base for intervening in negative
symptoms as a factor which contributes to the lack of targeted,
effective treatments.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. The Temporal Experience of Pleasure Model.
(Kring and Caponigro, 2010).
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important distinction between intact consummatory (“in themoment”)
pleasure and a speciﬁc deﬁcit in anticipatory pleasure experienced by
people with schizophrenia (Kring and Caponigro, 2010). The model is
cyclical and suggests that after an experience is initiated and enjoyed,
the memory of that experience, and the ability to create and maintain
a representation of it, contribute to anticipatory pleasure. Once pleasure
has been anticipated, motivation to seek out and complete that activity
is generated. Themodel has been extended to include ﬁndings from the
reward and neuroimaging literature which proposes additional con-
structs such as value computation and effort computation for inclusion
in the model (Kring and Barch, 2014). Research has focused on gather-
ing evidence across several methodologies to support the concepts de-
scribed in the model and this has been reviewed in two narrative
papers (Cohen et al., 2011; Strauss et al., 2011). However, the TEP
model proposes many constructs that contribute to the experience of
pleasure and they have yet to be assessed systematically to detect
which are empirically supported and should be prioritised as the foun-
dation for an evidence-based intervention.
The aim of this review is to recommend interventionswhichmay be
effective on the basis of empirical evidence and highlight the gaps in
knowledge that require further research. This will be achieved by sys-
tematically reviewing all experimental studies that include individuals
with schizophrenia, measure anhedonia using a validated assessment
tool and one of the components of the TEPmodel—consummatory plea-
sure,memory, executive functions/reward representation,: anticipatory
pleasure or approach motivation and behaviours.Table 1
List of psychometrically validated scales to assess anhedonia in schizophrenia.
Name of measure Reference: validation
study
Positive and Negative Syndrome Scale Kay et al. (1987)
Scale for the Assessment of Negative Symptoms Andreasen (1982)
Physical and Social Anhedonia Scales Chapman et al. (1976)
Temporal Experience of Scale Gard et al. (2006)
Clinical Assessment Interview for Negative Symptoms Horan et al. (2011)
Snaith Hamilton Pleasure Scale Snaith et al. (1995)
Brief Negative Symptoms Scale Kirkpatrick et al. (2011)2. Method
This systematic review was conducted following PRISMA guidelines
(Moher et al., 2009), see Appendix 2 for a completed PRISMA checklist.
2.1. Study eligibility
Studies were considered eligible if they:
• Included a majority of individuals with a diagnosis of schizophrenia
according to the Diagnostic and Statistical Manual of Mental Disorder
(American Psychiatric Association, 2013), ResearchDiagnostic Criteria
(Spitzer et al., 1978) or International Classiﬁcation of Diseases (World
Health Organisation, 1992).
• Assessed anhedonia using validated instruments shown by at least
one published validation study in people with schizophrenia (self-re-
port or clinical interview; see Table 1).
• Were written in English
• Reported empirical data
• Did not only include individuals with primary co-morbid disorders
e.g. substance abuse.
2.1.1. Search criteria
Both PubMed/Medline andPsycINFOwere searched up toApril 2015
by CE using the following keywords: schizophrenia and anhedonia. Al-
ternative search terms for anhedonia (e.g. pleasure, positive affect, and
reward) were excluded after initial searches produced a very high pro-
portion of irrelevant papers (i.e. 90%). Studies that only included partic-
ipants with co-morbid substance or alcohol abuse diagnoses (i.e.
investigated the impact of these co-morbid diagnoses on emotional ex-
perience) were excluded as anhedonia may be present due to this pri-
mary diagnosis and thus confound the investigation of the nature of
anhedonia in people with schizophrenia. This focus on anhedonia in
the context of negative symptoms of schizophrenia and not as the result
of affective disorders is also the reason for narrowing the search to
“schizophrenia” only. Recently both a systematic review and meta-
analysis (Elis et al., 2013; Fusar-Poli et al., 2014) have summarised the
limited effectiveness of currently available interventions for negative
Fig. 2. Consort diagram of systematic search.
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excluded from this review as the focus is on developing an evidence
base for future interventions as both reviews state this is currently
missing from the ﬁeld. The abstracts of all the retrieved papers
from these searches were initially scanned to exclude irrelevant
papers. References of recent reviews and meta-analyses (published
from 2010 onwards) were also hand-searched to identify any other
possible relevant studies. The included studies were reviewed by
the other authors.
The remaining empirical studies meeting the exclusion/inclusion
criteria detailed in the method were reviewed and if a construct
proposed in the TEP model (consummatory pleasure, memory, execu-
tive functions, working memory, anticipatory pleasure, approach moti-
vation and behaviours) was measured then the paper was included.Each study was categorised by the TEP construct measured and the
sample size (or number of studies ifmeta-analysis),measure of anhedo-
nia, methodology, and main ﬁndings were extracted and entered into
the full table of studies (See Appendix 1 for Table 1 and categorisation).
Rating the quality of the included studies was considered, however, the
heterogeneity of methodologies and variables across studies (e.g. fMRI,
structural fMRI, Likert scales, experience sampling, smell identiﬁcation
test, event related potentials) resulted in the detailed data (rather
than a single summary score) being more useful for a critical summary
of the evidence (see Table 1). Synthesising the information in this man-
ner allows for an assessment of the risk of bias when measuring each
construct (i.e. small samples, use of a limited measure). Incorporating
the main ﬁndings from each study in this table allows publication bias
(e.g. towards positive ﬁndings) to be considered.
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The initial search identiﬁed 1332 potentially eligible studies. The ref-
erences of three recent reviews (Cohen and Minor, 2010; Cohen et al.,
2011; Strauss and Gold, 2012) produced another 15 potentially eligible
studies. Once duplicates had been removed a total of 968 abstracts were
screened. Studies were not considered if the full text could not be
retrieved (n = 14), were not written in English (n = 85), did not use
systematic diagnostic criteria (n= 20), a validated assessment of anhe-
donia (n= 51), examined the effectiveness of an intervention (n= 17)
or studied primary co-morbid disorder (n = 6). Articles with unclear
relevancewere discussedwith other authors. As a result of the selection
criteria 256 papers detailing the results of 250 independent studies
were ﬁnally considered (see Fig. 2).
A large proportion of the included studies (30%) reported either the
prevalence or prognostic implications of anhedonia in people with
schizophrenia. These results show that anhedonia is a stable symptom
in individuals with schizophrenia (Buck and Lysaker, 2013; Dollfus
and Petit, 1995; Horan and Blanchard, 2003) and high levels predict
worse functional outcomes (e.g. Horan and Blanchard, 2003). These
ﬁndings are well established and will not be discussed further.
3.1. Measures of anhedonia
20 studieswere retrieved in the searchwhich assessed or validated a
measurement of anhedonia (see Table 1) and these differed in their
speciﬁcity for the severity of anhedonia. Traditional symptommeasures,
the Positive and Negative Syndrome Scale PANSS and Scale for the As-
sessment ofNegative Symptoms include anhedonia in thenegative symp-
tom ratings provided by this scale. As a result, it is often confoundedwith
activity levels and other negative symptoms such as asociality and
amotivation. Newermeasures, the Clinical Assessment Interview for Neg-
ative Symptoms and Brief Negative Symptom Scale, focus on measuring
anhedonia separately from other negative symptoms and independently
from the activity levels reported by that individual. The Chapman scales
were developed as an assessment of schizotypy and as such are grounded
in assumptions that may not apply to people with a diagnosis of schizo-
phrenia e.g. close friendships, family support and the opportunity to en-
gage in activities. The Temporal Experience of Pleasure Scale (TEPS) is
similar; it has been designed for use in both control and clinical popula-
tions and as a result assumes experiences occur in both groups which
may not be the case in the clinical group. In particular there may be
fewer opportunities for eating out, rollercoasters, and holidays. It also as-
sesses consummatory pleasure using questions such as “I love it when
people playwithmy hair”whichmay have limited validity as these expe-
riences are not occurring “in the moment”. The Snaith Hamilton Pleasure
Scale (SHAPS) is used rarely in the literature, it does focus on anhedonia
more speciﬁcally but without replication it is difﬁcult to assess its perfor-
mance as compared to the other available measures.
3.2. Consummatory pleasure
Theﬁnding that pleasureduring activities or stimuli presentation is in-
tact in peoplewith schizophrenia is themost consistent in this ﬁeld. A va-
riety of methods have been used to measure anhedonia experimentally
“in the moment” in the studies retrieved including: images, video clips,
food, faces, words, sounds, smells and mood induction (Burbridge and
Barch, 2007; Horan et al., 2006; Strauss and Herbener, 2011; Trémeau
et al., 2009). In all studies the participants rated how pleasant they
found the stimuli and individuals with schizophrenia reported similar
levels of pleasure to controls, this is conﬁrmed across studies in two
meta-analyses (Cohen and Minor, 2010; Yan et al., 2012). This ﬁnding
was replicated for arousal ratings (Llerena et al., 2012). These results sug-
gest that enjoyment of experiences “in the moment” is intact, an impor-
tant consideration in the development of a therapy. Clinicians may be
able to capitalise on current experience if they are targeting relatedprocesses such as anticipation. Although this is a well-established ﬁnding
it is important to note that the stimuli rated in an experimental context
are carefully controlled and often selected from a small group of
standardised stimuli e.g. International Affective Picture Scale (Lang et al.,
1999). Thismethod ofmeasuring pleasure has limited real-world applica-
tion but is valuable in studying short-term emotional responses. Technol-
ogy has now been established to provide a focus on everyday ratings of
enjoyment using experience sampling methodology (ESM) which over-
comes this limitation. In ESM studies questionnaires are completed sever-
al times a day prompted by a smartphone, digital watch or pager and so
this methodology captures “in the moment” experience during everyday
life. One study conducted an ESM study using phone calls 4 times a day to
assess consummatory pleasure and replicated theﬁnding of similar enjoy-
ment in people with schizophrenia and controls (Sanchez et al., 2014).
This was in the context of increased negative mood in people with
schizophrenia which had a weaker relationship with current enjoyment
than in controls. The results are highly applicable to real-world scenarios.
3.3. Memory
The TEP model proposes that following an activity, the memory of
the pleasure experienced and the details of the event, contribute to an-
ticipating future pleasure. It has therefore been hypothesised that those
individuals with schizophrenia who have poorer memory will also re-
port higher levels of anhedonia.
Several studies examined this relationship through memory task
performance and self-report measures of anhedonia (see Table 2). The
results are inconclusive with some authors reporting impairment in vi-
sual and recognitionmemory associatedwith anhedonia (Brebion et al.,
2007; Brebion et al., 2012; Kemali et al., 1987) but others reporting in-
tact, if not superior, non-spatial, implicit and recognition memory asso-
ciatedwith higher levels of anhedonia in individualswith schizophrenia
(Brebion et al., 1999; Harvey et al., 2009; Stevens et al., 2002). The con-
clusions from these studies are limited as all those conducted byBrebion
and colleagues include the same participants and the others include
small samples (n b 30). These small sample sizes also limit the power
of the studies to detect small-moderate correlations. As a resultmore in-
direct links, perhapswith other factors in themodel acting asmediators
or moderators, between anhedonia and emotional memory may be
missed in these studies. Clearer hypotheses regarding the types of
memory potentially involved e.g. memory for positive experiences, au-
tobiographical memory and newer, more speciﬁc, measures of anhedo-
nia (e.g. CAINS, BNSS) would enhance the validity and rigour of the
studies conducted.
Studies assessing emotional memory i.e. remembering the emotions
experienced during a previous event, report a consistent deﬁcit in people
with schizophrenia which is associated with self-reported anhedonia
(Herbener, 2008). One study (Herbener et al., 2007) with a larger sample
than those studieswith negative ﬁndings (n=33) demonstrated that, un-
like in healthy controls, positive emotion did not enhance delayed recogni-
tion memory but negative emotion did. This suggests that the emotional
memory deﬁcit may be speciﬁc to positive emotions— an important detail
to note in the development of an intervention. Support for the link comes
from studies on the brain where the hippocampus and amygdala play
key roles in the encoding-retrieval processes in emotional memory
(Cohen et al., 2011). Activation in these regions is correlated with self-
reported anhedonia during tasks involving emotional memory (Becerril
and Barch, 2011; Dowd and Barch, 2010). Emotional memory is therefore
a potential target for future interventions with a strong evidence base
supporting its relevance to anhedonia.
3.4. Executive functions and representation activation/maintenance
The TEP model proposes that a representation of previous experi-
ences and associated pleasure is activated andmaintained to inform an-
ticipatory pleasure. It has been suggested that the difﬁculty in building
124 C.J. Edwards et al. / Schizophrenia Research 168 (2015) 120–144or activating these representations may underlie high levels of self-
reported anhedonia (Burbridge and Barch, 2007; Cohen et al., 2011).
Individuals with schizophrenia may also struggle to access the repre-
sentation even if it is intact and maintained. These deﬁcits would result
in difﬁculties in using prior experiences when anticipating and there-
fore produce a failure to learn which activities had been enjoyable in
the past. Individuals experiencing these problems are unlikely to repeat
enjoyable activities (often seen in individuals with schizophrenia).
The difﬁculty in building or activating representations is hypothesised
to be due to the well-documented executive function deﬁcits (Burbridge
and Barch, 2007). However, there is little behavioural evidence to support
an association between executive functions and self-reported anhedonia
(See Table 3). In the studies considered in this review,we found no signif-
icant correlations between levels of anhedonia and performance on exec-
utive functioning tasks including the Wisconsin Card Sorting task, the
Verbal Fluency Test or the Stroop task e.g. (Larquet et al., 2010; Laurent
et al., 2000). It is striking that themajority of these studies used the Chap-
man psychosis proneness scales which are designed for use in non-
clinical populations to assess schizotypy andmaynot therefore accurately
capture the experience of individuals with schizophrenia i.e. asking them
to rate scenarios that assume they have close friends or access to leisure
activities. Replication with newer, more appropriate measures designed
for clinical participants would more accurately reﬂect the relevance of
this cognitive domain for anhedonia. A large proportion of the studies in-
cluded in the table did not measure anhedonia in the healthy control
group. In those studies which did include an appropriate measure for
the control group, such as the Chapman Scales, themajority did not report
analyses assessing the association between executive function and anhe-
donia. This is problematic as it limits the conclusions that can be drawn
regarding the deﬁcits in people with schizophrenia. The neuropsycholog-
ical tasks used e.g. the Wisconsin Card Sorting Task, the Go NoGo task,
may also not be associated with self-reported anhedonia because they
do not have an emotional component.
The neuroimaging literature shows different results. Reduced activa-
tion has been reported in the dorsolateral prefrontal cortex, ventrome-
dial prefrontal cortex, orbitofrontal cortex and the ventral anterior
cingulate cortex during emotive or reward processing tasks that corre-
lates with high levels of self-reported anhedonia (Dowd and Barch,
2012; Park et al., 2015; Park et al., 2009; Ursu et al., 2011; Wang et al.,
2003) although two studies with smaller sample sizes did not ﬁnd
these links (Gradin et al., 2011; Simon et al., 2010) and one reported a
link with avolition but not anhedonia (Mucci et al., 2015). The majority
of evidence from this group of studies suggests that deﬁcits in exec-
utive functions in schizophrenia are associated with high levels of
anhedonia. However, these ﬁndings are the result of correlational
analyses and not group-comparisons which reduces the strength of
this conclusion.
These regions of the brain also are implicated dopaminergic trans-
mission involved in the process of anticipating future pleasure, see the
following papers for a review (Gold et al., 2008; Kring and Barch,
2014; Strauss et al., 2013). The association between dopamine and
anticipatory pleasure will be discussed in detail in the “Anticipatory
Pleasure” section of this review. Gambling and reward-based tasks
were used in these studies which increase the emotional content and
therefore relevance to everyday life. These tasks are also more emotive
than the neuropsychological tasks used in the behavioural studies
described above and are therefore a more speciﬁc assessment of
behaviours related to emotive rewards. Increased relevance to everyday
life in comparison to neuropsychological assessments may explain the
differing results using these twomethodologies. Future research should
be conductedwith laboratory tasks containing an emotional component
to gain a fuller understanding of any deﬁcits in executive functions that
may contribute to anhedonia.
Experimental tasks also need to be developed which measure the
processes involved in creating and maintaining representations. In one
such task participants rated the emotional intensity of an image andthen repeated this rating after a 3 s delay (Gard et al., 2011). Individuals
with schizophrenia were less consistent in their ratings across the delay
than controls, demonstrating a deﬁcit in representationmaintenance of
the pleasure experienced over a very short delay. A recent study used
the Sensory-Speciﬁc Satiety Task to demonstrate that individuals with
schizophrenia have difﬁculty accurately updating their representations
of value compared to controls (Waltz et al., 2015). In the task people
with schizophrenia did not show a satiety effect speciﬁc to the stimuli
experienced unlike controls. Future research should prioritise dynamic
tasks such as these which examine how reward representation changes
over time. A further advantage of the development of innovative tasks
such as these is that the conclusions drawn are based on group compar-
isons and effect sizes and not correlational analyses. This strengthens
the rigour of the studies conducted and the reliability of the ﬁndings.
Although extensive research has been conducted into improving
cognition in people with schizophrenia (Wykes et al., 2011), no studies
have yet reported the effect that an improvement in executive functions
has on the experience of pleasure.
3.5. Anticipatory pleasure
This component of the TEP model has been the major theoretical
driving force in the last two decades. Surprisingly, despite this focus in
the theoretical literature, themajority of direct evidence for an anticipa-
tory pleasure deﬁcit comes from ﬁndings using the TEPS and not exper-
imental tasks. This self-report measure asks participants to rate the
truth of a series of statements (e.g. I look forward to a lot of things in
my life) categorised as anticipatory or consummatory. The majority of
studies report signiﬁcantly lower anticipatory pleasure subscale scores
in people with schizophrenia compared to controls and individuals
with low negative symptoms but similar consummatory pleasure
(Chan et al., 2012; Gard et al., 2007; Mote et al., 2014). One study, how-
ever, reports the opposite ﬁnding (Strauss et al., 2011) and the authors
hypothesise that this may be due to the anticipatory ratings beingmore
inﬂuenced by other factors (e.g. mood) and therefore less reliable across
studies than the consummatory ratings.
One small study extends the use of self-reportmeasures by using ex-
perience sampling methodology. This study reported reduced anticipa-
tory pleasure in everyday life in the schizophrenia group compared to
controls, alongside intact consummatory pleasure (Gard et al., 2007).
Although the opposite ﬁnding of increased anticipatory pleasure in peo-
ple with schizophrenia compared to controls was reported in a recent,
larger ESM study (Gard et al., 2014). The ﬁndings from this study and
self-report measures support anticipatory pleasure as potential thera-
peutic target but self-report alone is a narrow evidence base on which
to develop an intervention as it is susceptible to both memory deﬁcits
and desirability biases.
Despite the substantial evidence from studies using self-report, ex-
perimental studies have so far failed to replicate them. Tremeau and col-
leagues conducted two studies using the same method. Participants
were told details of the task they were about to complete and asked to
rate how much they thought they would enjoy it (Trémeau et al.,
2010; Trémeau et al., 2014). The study ﬁndings were different and nei-
ther supported a reduced anticipatory pleasure response. In the ﬁrst
study individuals with schizophrenia were no different to controls and
in the second their anticipatory pleasure was increased compared to
controls. Choi et al. (2013) also showed no differences in their anticipa-
tion in a task where participants preview a ﬁlm prior to the full length
feature. These experimental tasks are the beginning of an expanding
ﬁeld and may be limited by their use of previews and descriptions to
generate anticipatory pleasure ratings. The more common process in
everyday life is to use prior experience to generate emotional predic-
tions regarding future events. Targeting this process may reveal speciﬁc
deﬁcits in schizophrenia as well as being more ecologically relevant.
It is hypothesised by Kring and Barch (2014) that the role of dopa-
mine in signalling prediction errors may contribute to the anticipatory
Table 2
A table reporting correlations between scores on tasks assessing memory and anhedonia scores.
Study Task Type of memory assessed mean
score (SD)
Anhedonia measure
mean score (SD)
Participants Results
Relation between emotional face
memory and social anhedonia in
schizophrenia (Harvey et al., 2009).
Emotional face
recognition
memory task.
Emotional face recognition memory-recognition
accuracy and response bias.
SZ
Recognition Accuracy = 0.31–0.42 (0.12–0.16).
Response Bias =−0.05 to−0.13 (0.21).
Controls
Recognition Accuracy = 0.35–0.52 (0.12–0.17).
Response Bias =−0.14 – .02 (0.18–0.21).
Chapman scales 11.1 (5.6) 29 patients with
schizophrenia and 27
matched healthy controls.
No signiﬁcant correlations with social anhedonia
scores and memory performance variables in the
patient or control group (ps N .01 required for
signiﬁcance).
Visual memory errors in schizophrenic
patients with auditory and visual
hallucinations (Brebion et al., 2007).
Visual memory
task.
Visual recognition memory.
Spatial context memory.
Discrimination accuracy: black & white = .56 (0.23)
colour = .59 (.23–.24) Response bias = b&w= .34
(.22) colour = .36 (.22). Spatial errors = b&w=
3.51 (1.90) colour = 3.98 (1.72).
SANS
Mean not reported.
41 schizophrenia patients. Anhedonia signiﬁcantly correlated with a reduction in
false recognition errors (p b .005). Spatial context
errors not signiﬁcantly associated with anhedonia.
Failure of positive but not negative
emotional valence to enhance memory
in schizophrenia (Herbener et al.,
2007).
24 hr image
recognition task
Long term recognition memory Chapman scales Social
anhedonia = 13.29 (7.66)
Physical anhedonia =
16.23 (8.09).
33 patients with
schizophrenia, 28 healthy
controls.
Analyses between anhedonia scales and recognition
accuracy not conducted.
Temporal context discrimination in
patients with schizophrenia:
associations with auditory
hallucinations and negative symptoms.
Brebion et al., 2007
List discrimination
task.
Temporal memory for verbal stimuli (words) -
memory of order in which they were presented- 1st
list or 2nd list.
SZ
Misattributions of previous-list to the recent list:
High freq words = 2.76 (1.39) Low freq words =
2.49 (1.48)
Misattributions of recent-list words to the previous
list: High-freq words = 2.93 (1.17)
Low-freq words = 2.34 (1.49) Controls
Misattributions of previous-list to the recent list:
High freq words = 1.91 (1.62) Low freq words =
1.63 (1.50)
Misattributions of recent-list words to the
previous list: High-freq words = 2.00 (1.51)
Low-freq words = 1.77 (1.41)
SANS 20.3 (14.6) 41 outpatients with
schizophrenia, 43 healthy
controls.
Affective ﬂattening and anhedonia signiﬁcantly
inversely correlated with errors on this task i.e. a
higher anhedonia score was associated with a better
performance (p b .009).
No measure of anhedonia conducted in controls.
Does anhedonia in schizophrenia reﬂect
faulty memory for subjectively
experienced emotions?
Horan et al., 2006
Foods and ﬁlm
clips-pleasure
ratings and
delayed recall test.
4 hr delayed discrimination task- recognition of
stimuli and free recall of previous pleasure ratings.
Chapman scales physical
anhedonia = 19.3 (7.5)
Social anhedonia = 17.5
(8.7)
30 schizophrenia patients. 31
healthy controls.
No signiﬁcant differences between patients and
controls in immediate ratings or the recall of these
ratings. No results reported for anhedonia and
accuracy of recognition.
Hallucinations, negative symptoms, and
response bias in a verbal recognition
task in schizophrenia.
Brebion et al., 2005
Word recognition
task.
Immediate verbal recognition memory (short-term).
Delayed (5 min) verbal recognition memory
(long-term). Delayed (5 min) verbal free recall.
Recognition accuracy = .45 (.17) Response bias =
.25 (.13).
SANS
20.5 (14.7)
40 patients with
schizophrenia.
Higher levels of anhedonia signiﬁcantly negatively
correlate with global false recognitions (p b .05),
signiﬁcant for delayed (r = 0.33, p b .05) and trend
for immediate (r =− .3, p b .08).
Implicit and explicit learning in
schizophrenics treated with
olanzapine and with classic
neuroleptics.
Stevens et al., 2002
Serial reaction time
task Eye-blink
conditioning
Explicit
visuospatial
memory.
Implicit sequence learning. Correct responses (%)
Classic NLs 1st half = 94 (6.2) 2nd half = 91.3 (9.4)
Olanzapine 1st half = 94.6 (3.5) 2nd half = 94.7
(3.4) Implicit learning. Median trials to reach
criterion. Classic NLs = 16 Olanzapine = 15 Spatial
memory. Correct responses (%) Classic NL = 73
(10.5)
Olanzapine = 75 (12.3)
SHAPS
Classic NLs = 8.3 (1.1)
Olanzapine = 7.6 (0.8)
SANS Classic NLs = 11.2
(9.3) Olanzapine = 12.1
(17.2)
25 patients with
schizophrenia treated with
olanzapine 25 patients with
schizophrenia taking classic
neuroleptics, 25 healthy
controls.
SANS and SHAPS did not differ between patient
groups. No measure of anhedonia in control group.
Anhedonia measures did not correlatewith any of the
learning performance scores (rs b .02, ps N .05).
(continued on next page)
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126 C.J. Edwards et al. / Schizophrenia Research 168 (2015) 120–144pleasure construct in the TEP Model. Abnormal prediction error signal-
ling in the striatum in people with schizophrenia has been seen in fMRI
studies, with both reduced and increased activation in response to unex-
pected rewards reported (Gradin et al., 2011; Morris et al., 2012; Murray
et al., 2008). One study found a speciﬁc reduction in positive prediction
error (more reward than expected) signalling in the striatumwhilst neg-
ative prediction error (less reward than expected) was found to be intact
(Waltz et al., 2009). In contrast, Dowd and Barch (2012) found intact pos-
itive prediction error responses in people with schizophrenia, although
these were seen in cortical regions and not the striatum. In sum, it
seems that prediction error signalling is abnormal in schizophrenia and
may contribute to anticipatory pleasure deﬁcits although the direction
and magnitude of the differences varies across studies.
These ﬁndings raised the important question of the role of dopamine
in anticipatory pleasure, and therefore the potential effects of antipsy-
chotic medication. In un-medicated people with schizophrenia reduced
ventral striatum activity during anticipation of reward has been report-
ed (Esslinger et al., 2012; Juckel et al., 2006b). One study which com-
pared drug-free patients and those being treated with neuroleptics
found that dopamine D2/D3 receptor availability was negatively corre-
latedwith affective ﬂattening asmeasured by the SANS but not anhedo-
nia/social withdrawal (Heinz et al., 1998). This ﬁnding was replicated
(Schmidt et al., 2001) and the authors suggested that patients who ex-
perience dopaminergic dysfunction are able to experience pleasure but
may struggle to respond to external stimuli which prompt them to seek
it out. This supports the ﬁnding that antipsychotic medicationmay have
a bigger impact on anticipatory rather than consummatory pleasure. It
appears that reduced activation of the ventral striatum in response to
rewarding cuesmay bemore pronounced in those people taking typical
antipsychotics but not those taking atypical antipsychotics; with this ef-
fect being correlated with negative symptom severity in those taking
typical antipsychotics only (Juckel et al., 2006a; Kirsch et al., 2007;
Schlagenhauf et al., 2008; Simon et al., 2010; Walter et al., 2009). The
limited behavioural studies have consistently reported no association
between medication type/dosage and anticipatory pleasure (Choi
et al., 2013; Trémeau et al., 2010). This is an important area which re-
quires clariﬁcation as it is possible that the effect of medication may
not translate into behavioural changes. Alternatively, it may be that
the measures used in these studies (most commonly the Chapman
Scales) are not detecting changes at the behavioural level. However,
the small sample sizes in the neuroimaging studies make it unlikely
such a small association has been detected. The vast majority of studies
considered in this review include individuals with chronic schizophre-
nia, who have been prescribed high levels of antipsychotic medication.
The association found here between neuroleptics and abnormal antici-
pation may therefore not generalise to all individuals with this diagno-
sis, particularly not those experiencing their ﬁrst episode
3.6. Approach motivation/behaviour
The ﬁnal stage in the cycle is the motivation and behaviours which,
depending on the outcome, may lead to the activity occurring again.
Only three studies were retrieved which investigated the link between
these factors and anhedonia. Two studies used self-report measures of
motivation—the Motivational Trait Questionnaire (MTQ) (Barch et al.,
2008) and motivation ratings using Likert scales in relation to a task
(Trémeau et al., 2014). There were no differences between groups on
any subscales on the MTQ (except lower anxiety-linked motivation in
people with schizophrenia) or the ratings given during the Tremeau
study. The ﬁnal study used an experimental task in which participants
had to press a button repeatedly to avoid or view a picture they had pre-
viously rated (Heerey and Gold, 2007). Although the button press fre-
quency was comparable between groups, people with schizophrenia
failed to discriminate between pleasant and unpleasant images as consis-
tently as controls. Individuals with schizophrenia did not, as expected,
press the button less for images they had previously found unpleasant,
Table 3
A table reporting correlations between measures of executive functions and anhedonia scores.
Study Task Areas of cognition
mean (SD)
Measure of
anhedonia mean
(SD)
Sample Results
Impaired decision making in schizophrenia
spectrum and orbitofrontal cortex lesion
patients (Larquet et al., 2010).
WAIS III
The Stroop test, the trail
making test, verbal ﬂuency
test, Wisconsin Card
Sorting Task (WCST).
IQ = 80.6 (16.2)
Executive
Functions
Stroop_a = 73.8 (15.7)
Stroop_b = 49.42 (13.9)
Stroop_c = 140.45 (39.7)
Trail making test_a = 48.3 (15.8)
Trail making test_b = 130.7 (74.7)
Fluency_letters = 17.19 (5.1)
Fluency_animals = 24 (5.4)
WCST = 5.14 (1.9)
WCST_errors = 3.2 (3.98)
Chapman scales
Social anhedonia = 16 (6.3)
Physical anhedonia = 20.4
(9.4)
21 schizophrenia spectrum
patients
10 orbitofrontal cortex
lesion patients and 20
healthy controls.
No signiﬁcant correlations betweenWCST,
Stroop, trial making or ﬂuency test and
anhedonia in schizophrenia spectrum
patients
(ps N 1)
No analysis of these relationships was
conducted in the control group.
Deﬁcits in positive reinforcement learning and
uncertainty-driven exploration are associated
with distinct aspects of negative symptoms in
schizophrenia (Strauss et al., 2011a)
Go NoGo Task Reinforcement learning
Data reported in graph format.
Uncertainty driven exploration
High negative symptom group = 1187 (1561)
Low negative symptom group = 1323 (1678)
SANS
Median split = 38.39.
51 patients with
schizophrenia, 39
age-matched healthy
controls.
Intact NoGo but impaired Go learning in
schizophrenia spectrum (p = 0.003).
High negative symptom patients had a
greater impairment in Go learning with
slower speeding up of RTs compared to
the other groups (p = 0.01).
Performance did not correlate with SANS
scores.
Reduced uncertainty driven exploration
in the task was signiﬁcantly correlated
with anhedonia/asociality only — (p b
0.05).
No measure of anhedonia in the control
group.
The emotional paradox: dissociation between
explicit and implicit processing of emotional
prosody in schizophrenia (Roux et al., 2010).
Emotional stroop task. Executive functions.
Accuracy: congruent = 0.849 (0.378)
Incongruent = 0.828 (0.358)
Reaction time (ms): congruent = 1308.9
(488.9)
Incongruent = 1338.0 (517.4)
PANSS negative subscale
24 (5.1)
Chapman scales
Physical anhedonia = 17.9
(9.0)
Social anhedonia = 15.2 (5.8)
21 schizophrenia spectrum
patients
21 healthy controls.
Higher reaction times on stroop task
associated at trend level with social
anhedonia (p = .052) but not physical
anhedonia (p = 0.6).
Correlational analysis not performed in
control group.
The emotional Stroop task: a comparison
between schizophrenic subjects and controls
(Demily et al., 2010).
Emotional stroop task Executive functions
Reaction times:
Positive words = 1134 (168)
Negative words = 1132 (169)
Neutral words = 1048 (158)
Symbols = 944 (133)
Four stimuli = 1077 (158)
Number of errors = 3.4%.
PANSS negative subscale
21.17 (3.11)
Chapman scales
Physical anhedonia = 22 (7.9)
Social anhedonia = 16.1 (4.3)
21 patients with
schizophrenia spectrum
disorders
20 healthy controls.
No signiﬁcant correlations between
Stroop task and social anhedonia (ps N
0.69) or physical anhedonia (ps N 0.55)
in schizophrenia.
No correlational analyses conducted for
controls.
Executive/attentional performance and
measures of schizotypy in patients with
schizophrenia spectrum and in their
nonpsychotic ﬁrst-degree relatives (Laurent
et al., 2000).
Degraded
Stimulus-Continuous
Performance Test.
Forced-choice span of
apprehension test.
Digit symbol substitution
test
Trail making A+B
Verbal ﬂuency
Stroop task
WCST
Attention
DS-CPT perceptual sensitivity =
SZ: 3.11 (0.83)
HC: 3.80 (0.91)
Perceptual evidence before decision=
SZ: 1.15 (1.13)
HC: 0.72 (1.00)
Reaction time (ms) = SZ: 557 (82)
HC: 477 (60)
SPAN (% correct):
3-letter = SZ: 96.6 (4.8)
HC: 96.5 (3.5)
12-letter = SZ: 78.8 (8.4)
HC: 81.7 (7.4)
PANSS negative subscale
23.9 (7.3)
SZ
Chapman Scales
Physical anhedonia = 20.5
(8.7)
Social anhedonia = 13.7 (5.3)
Controls
Chapman scales
Physical anhedonia = 11.8
(6.3)
Social anhedonia = 6.5 (3.2)
23 schizophrenia spectrum
outpatients.
At-risk group of 25 parents
and 22 siblings.
34 healthy controls.
No signiﬁcant correlations between any of
these cognitive measures and the
Chapman scales in the patient group (ps
N .05)
(continued on next page)
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Table 3 (continued)
Study Task Areas of cognition
mean (SD)
Measure of
anhedonia mean
(SD)
Sample Results
Reaction time (ms):
3-letter = SZ: 786 (165)
HC: 655 (89)
12-letter = SZ: 1101 (266)
HC: 887 (171)
Speed of processing.
SZ: 42.7 (11.1)
HC: 57.7 (11.1)
Executive functions
Trail making A (s) = SZ: 3.62 (0.38)
HC: 3.54 (0.40)
Trail Making B (s) = SZ: 4.63 (0.49)
HC: 4.22 (0.36)
Verbal ﬂuency letters = SZ: 54.3 (17.6)
HC: 72.5 (16.8)
Verbal ﬂuency categories = SZ: 40.6 (10.1)
HC: 55.9 (9.7)
Stroop (interference) = SZ: 1.98 (6.5)
HC: 5.2 (7.3)
WCST preservative errors = SZ: 27.3 (26.0)
HC: 17 (1.8)
WCST categories achieved = SZ: 3.13 (2.34)
HC: 4.63 (1.67)
Relations between neuropsychological
vulnerability markers and negative symptoms
in schizophrenia (Suslow et al., 1998).
Visual backward masking
task.
Span of apprehension test.
Degraded
stimulus-continuous
performance test
WCST.
Information processing.
Backward masking (hit rate):
No information mask-ISI 43 ms = 73.9 (18.6)
ISI 114 ms = 85.0 (13.4)
Letter mask-ISI 43 ms = 46.3 (15.3)
ISI 114 ms = 78.3 (16.9)
Attention
SPAN (identiﬁcations) 12-letter array = 47.8
(6.4)
DS-CPT false alarm rate = 0.08 (0.07)
sensitivity = 0.89 (0.08)
Executive functions.
Preservative errors = 10.2 (11.3)
Non-preservative errors = 27.2 (21.4)
SANS
Anhedonia-asociality = 6.8
(4.1)
31 patients with
predominantly negative
symptoms.
Anhedonia-asociality signiﬁcantly
negatively correlated with preservative
errors on WCST when medication is
controlled for (r =−0.48, p = b .001).
No correlations with the other tasks.
Affective and social-behavioural correlates of
physical and social anhedonia in
schizophrenia (Blanchard et al., 1994).
WAIS-R IQ
Mean (SD) not reported.
Chapman scales
Physical anhedonia = 16.92
(8.70)
Social anhedonia = 15.15 (6.69)
SANS anhedonia-asociality =
2.43 (1.19)
26 sz patients, 9
schizoaffective disorder
patients, 9 bipolar patients
No signiﬁcant correlations between
WAIS-R Information or vocabulary
sub-tests and either Physical or social
anhedonia in the schizophrenia
spectrum group (rs b .21, ps N .05).
Conditional associative learning in drug-free
schizophrenic patients (Kemali et al., 1987).
Spatial and non-spatial
conditional associative
learning tasks
Spatial (SCAL) and Non-Spatial (NSCAL)
Conditional Associative Learning Ability
SCAL
Total errors = 131.2 (59.3)
Total time (s) = 546.5 (202.6)
Mean time (s) = 37 (13)
Correct trials (%) = 5.3 (10.1)
Correct items (%) = 43.9 (21.4)
Learned associations = 3.4 (1.9)
NSCAL
Total errors = 119.4 (70.1)
Total time (s) = 609.4 (230.6)
Mean time (s) = 43.6 (13.5)
Correct trials (%) = 13.5 (16.6)
Correct items (%) = 50.4 (19.3)
Learned associations = 3.9 (2.0)
SANS
Mean (SD) not reported.
21 male drug-free
schizophrenia spectrum
patients, 19 healthy
controls.
No correlation between spatial
conditioning learning and SANS.
Number of errors, reaction time and
number of learned associations in the
non-spatial learning task negatively
correlated with SANS anhedonia
subscales (rs =−0.5, ps b .05).
No measure of anhedonia in the control
group.
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Intrinsic motivation in schizophrenia:
Relationships to cognitive function,
depression, anxiety, and personality.
Barch et al., 2008
WAIS III
AX-continuous
Performance task
2-back version of the n
back task
IQ
WAIS-III Vocab = SZ: 8.5 (3.7)
HC: 10.4 (3.6)
WAIS-III matrix reasoning = SZ: 9.4 (3.3)
HC: 11.9 (3.9)
Attention-context processing.
Short-delay performance:
AX errors = SZ: 0.06 (0.08)
HC: 0.01 (0.02)
AY errors = SZ: 0.13 (0.15)
HC: 0.09 (0.02)
BX errors = SZ: 0.24 (0.31)
HC: 0.09 (0.17)
BY errors = SZ: 0.04 (0.11)
HC: 0.03 (0.14)
Context sensitivity = SZ: 2.5 (1.3)
HC: 3.4 (0.6)
Long-delay performance:
AX errors = SZ: 0.21 (0.24)
HC: 0.13 (0.25)
AY errors = SZ: 0.09 (0.16)
HC: 0.12 (0.18)
BX errors = SZ: 0.25 (0.34)
HC: 0.11 (0.18)
BY errors = SZ: 0.4 (0.11)
HC: 0.4 (0.17)
Context sensitivity = SZ: 1.8 (1.2)
HC: 2.6 (1.4)
Working memory
0-back accuracy = SZ: 0.94 (0.10)
HC: 0.95 (0.09)
1-back accuracy = SZ: 0.88 (0.09)
HC: 0.93 (0.08)
2-back accuracy = SZ: 0.79 (0.10)
HC: 0.87 (0.10)
SANS
Anhedonia-asociality = 2.6
(1.3)
SZ
Chapman scales
Physical anhedonia = 17.0
(5.7)
Social anhedonia = 14.7 (4.8)
HC
Chapman scales
Physical anhedonia = 11.7
(4.5)
Social anhedonia = 11.5 (4.8)
66 sz patients, 44 healthy
controls.
No signiﬁcant associations between any
motivation measures and any of the
measures of cognition except for
‘motivation related to anxiety’which was
negatively correlatedwith AX-CPT
performance (r =−.36, p b .05).
All three measures of cognition (WAIS-II,
AX-CPT, 2-back) associated with motivation
measures in the control group- personal
mastery, competitive excellence and
‘motivation related to anxiety’.
No results reported for anhedonia and
cognition.
Attentional abilities and measures of
schizotypy: their variation and covariation in
schizophrenic patients, their siblings, and
normal control subjects (Franke et al., 1994).
Continuous performance
test - Identical Pairs.
Attention
Fast numbers (no distraction):
Sensitivity=
SZ: 1.25 (0.68)
HR: 1.38 (0.68)
HC: 1.61 (0.69)
Response criterion = SZ: 0.04 (0.70)
HR:−0.24 (0.47)
HC:−0.33 (0.68)
Random trials = SZ: 2.76 (2.77)
HR: 1.96 (2.44)
HC: 1.67 (2.61)
Fast shapes (no distraction):
Sensitivity = SZ: 1.18 (0.62)
HR: 1.56 (0.68)
HC: 1.98 (0.75)
Response criterion = SZ: 0.32 (0.57)
HR: 0.25 (0.50)
HC:−0.15 (1.01)
Random trials = SZ: 4.40 (2.58)
HR: 3.24 (2.73)
Chapman scales
Physical anhedonia=
SZ: 23.3 (11.2)
Siblings (HR): 15.7 (3.4)
HC: 11.8 (2.9)
35 sz patients, 26 healthy
siblings and 35 controls.
Performance on CPT did not correlate
signiﬁcantly with anhedonia scores in
the schizophrenia spectrum, healthy
control or high-risk siblings group.
(continued on next page)
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Table 3 (continued)
Study Task Areas of cognition
mean (SD)
Measure of
anhedonia mean
(SD)
Sample Results
HC: 2.24 (2.68)
Fast numbers (distraction):
Sensitivity = SZ: 0.95 (0.43)
HR: 1.02 (0.60)
HC: 1.36 (0.69)
Response criterion = SZ: 0.26 (0.58)
HR: 0.12 (0.65)
HC:−1.16 (0.43)
Random trials = SZ: 3.91 (2.75)
HR: 3.83 (2.76)
HC: 3.80 (2.49)
Fast shapes (distraction):
Sensitivity = SZ: 1.02 (0.64)
HR: 1.81 (0.94)
HC: 2.23 (1.03)
Response criterion = SZ: 0.28 (0.58)
HR:−0.04 (0.83)
HC: 0.06 (1.20)
Random trials = SZ: 4.35 (2.74)
HR: 3.13 (2.80)
HC: 2.48 (2.63)
Slow numbers (no distraction):
Sensitivity = SZ: 1.36 (0.66)
HR: 1.85 (0.77)
HC: 2.33 (1.01)
Response criterion = SZ: 0.08 (0.92)
HR:−0.19 (1.00)
HC:−0.30 (1.02)
Random trials = SZ: 2.57 (2.73)
HR: 1.21 (2.32)
HC: 1.02 (2.09)
Slow shapes (no distraction):
Sensitivity = SZ: 1.66 (1.03)
HR: 2.34 (1.10)
HC: 2.99 (0.93)
Response criterion = SZ: 0.25 (1.20)
HR: 0.37 (1.20)
HC:−0.05 (1.30)
Random trials = SZ: 3.40 (2.92)
HR: 1.97 (2.62)
HC: 1.27 (2.20)
Probabilistic reversal learning impairments in
schizophrenia: further evidence of
orbitofrontal dysfunction (Waltz and Gold,
2007).
Probabilistic reversal
learning task
Rapid reinforcement learning
Reported in graph form.
SANS
33.18 (16.82)
34 patients with
schizophrenia, 26 controls.
Patients show impairment in reversal
learning — fewer successful reversals (p =
0.008). No signiﬁcant association of reversal
learning with anhedonia subscale of SANS
(P = 0.42). Trendwith affective blunting
(0.06).
No measure of anhedonia in the control
group.
Inﬂuence of emotional processing on working
memory in schizophrenia spectrum (Becerril
& Barch, 2011).
2-back working memory
task with emotional faces
Accuracy and reaction times during task-
reported in graph form.
Scores per item.
Chapman Scales
Social Anhedonia
SZ: 4.92 (2.1)
HC: 2.35 (2.2)
Physical Anhedonia
SZ: 6.76 (4.17)
HC: 3.71 (3.1)
SANS
1.84 (0.95)
38 patients with
schizophrenia, 32 controls.
No signiﬁcant associations in either group
between any measure of anhedonia and
accuracy or reaction times on the 2-back
working memory task.
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Reward processing in schizophrenia: a deﬁcit in
the representation of value (Gold et al., 2008).
Speeded button pressing
for pictures of different
valence.
Delayed discounting tasks.
Wisconsin Card-Sorting
Task
Probabilistic Reversal
Learning Task
Frank Probabilistic
Selection Paradigm
Reported in graph form. SANS Summary sults across 8
studies.
Correlations consistently observed below
.3–.4 and non-signiﬁcant with all these
tasks.
No anhedonia measure in the control
group.
Cognitive correlates of schizophrenia spectrum
signs and symptoms: II. Emotional
disturbances.
Berenbaum et al. (2008)
Verbal and design ﬂuency
tasks. Working memory
tasks- reading span and
AX-CPT.
Digit span forward subtest
of WAIS-R as measure of
attention.
Lateralised motor
performance task.
Not reported SANS
Anhedonia
3 (0.5)
47 people ith
schizophr ia spectrum
disorder.
No association between anhedonia and
ﬂuency, working memory, digit span or
episodic memory tasks.
Anhedonia negatively correlated with
lateralized task performance.
The relationship between negative symptoms
and neuropsychological performance.
Hammer et al. (1995)
WAIS-R verbal and
performance scales
The ﬁnger tapping test
Trail making test (A and B)
WCST
Word ﬂuency
Rey Auditory Verbal
Learning Test
(RAVLT)—verbal memory.
Benton Visual Retention
Test Form (BVRT)—visual
memory.
Not reported SANS 65 people ith
schizophr ia.
Anhedonia subscale of the SANS
signiﬁcantly associated with word
ﬂuency (r =−0.27), perseverative
errors on the WCST (0.30) and reaction
times on the Trail Making Test
(A) (0.27).
Anhedonia and the experience of emotion in
individuals with schizophrenia (Burbridge
and Barch, 2007).
California Verbal Learning
Test (CVLT)
Digit span backward
CVLT-2 short delay free recall
SZ: 7.7 (3.0)
HC: 11.6 (3.2)
Digit span backward
SZ: 6.4 (2.3)
HC: 7.5 (2.3)
Chapman scales
Social anhedonia
SZ: 38.2 (21.2)
HC: 20.9 (15.4)
Physical anhedonia
SZ: 27.4 (16.7)
HC: 15.0 (9.5)
49 people ith
schizophr ia, 47 controls.
No association between Chapman scale
scores and cognitive measures in either
group.
Impaired modulation of attention and emotion
in schizophrenia (Dichter et al., 2010).
Forced-choice visual
oddball task
fMRI
Accuracy mean (SE)
Aversives
0.88 (0.027)
Circles
0.68 (0.059)
Neutrals
0.90 (0.025)
Reaction times mean (SE)
Aversives
674.54 (62.08)
Circles
605.57 (21.56)
Neutrals
614.71 (37.60)
SANS
Anhedonia-asociality
2.17 (1.80)
16 individ ls with
schizophr ia spectrum
disorder,
13 contro
No association between behavioural
scores on the task and any SANS
subscales.
No measure of anhedonia in the control
group.
(continued on next page)
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Table 3 (continued)
Study Task Areas of cognition
mean (SD)
Measure of
anhedonia mean
(SD)
Sample Results
Correlations between clinical symptoms,
working memory functions and structural
brain abnormalities in men with
schizophrenia (Szendi et al., 2006).
Digit span (forwards and
backwards)
Nonword repetition test
Corsi blocks
Visual patterns test
WCST
Towers of Hanoi
Letter and Category Fluen-
cy Task
WCST categories
4 (2.35)
Perseverative errors %
16.23 (8.32)
Conceptual level responses %
52.31 (27.21)
Failure to maintain set
0.54 (0.97)
Digit span
Forward
5.77 (1.17)
Backward
4.23 (1.01)
Nonword repetition test
6.23 (1.09)
Corsi blocks forward
6.46 (0.88)
Corsi blocks backward
5.85 (1.35)
Visual patterns test
7.54 (1.81)
Tower of Hanoi (steps)
11 (5.31)
Letter ﬂuency (words)
8.56 (2.41)
Letter ﬂuency (errors)
1.15 (0.99)
Category ﬂuency (words)
14.49 (3.26)
Category ﬂuency (errors)
0.91 (0.82)
SANS
Anhedonia
1.6 (1.2)
13 males with
schizophrenia, 13 male
controls.
Anhedonia scores correlated with Corsi
backwards task scores (r =− .056) and
performance on The Tower of Hanoi task
(−0.62).
No measure of anhedonia in the control
group.
Anhedonia in prolonged schizophrenia
spectrum patients with relatively lower vs.
higher levels of depression disorders:
Associations with deﬁcits in social cognition
and metacognition (Buck et al., 2014).
Wisconsin Card Sorting
Task
WCST Number of categories correct
High depression/high anhedonia: 3.65 (2.11)
Low depression/low anhedonia: 3.81 (1.99)
Low depression/high anhedonia: 2.95 (2.33)
PANSS Negative
High depression/high
anhedonia: 20.48 (5.36)
Low depression/low
anhedonia: 16.85 (4.43)
Low depression/high
anhedonia: 21.15 (4.91)
163 SCZ; 52 high
depression/high
anhedonia, 52 low
depression/low anhedonia,
59 low depression/high
anhedonia.
No difference between groups with
differing levels of anhedonia and scores
on the WCST.
Deﬁcits in emotion based decision-making in
schizophrenia; a new insight based on the
Iowa Gambling Task (Matsuzawa et al., 2015).
Iowa gambling task Reported in graph form. SANS total
76.1 (13.9)
61 people with
schizophrenia and 50 age-
and sex-matched controls.
Card choices
(advantageous/disadvantageous)
correlate with SANS anhedonia-asociality.
No measure of anhedonia in the control
group.
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133C.J. Edwards et al. / Schizophrenia Research 168 (2015) 120–144or increase presses for images they had previously found pleasant. These
ﬁndings describe a deﬁcit in linking goals or preferences with actions.
Some support for this hypothesis comes from an experience sampling
study which reported that individuals with schizophrenia completed
fewer goal-directed activities than controls (Gard et al., 2007). A recent
ESM study extended this by asking participants and independent raters
to rate the effort required for the goals set by the participants in everyday
life (Gard et al., 2014). People with schizophrenia were more inaccurate
than controls compared to the independent raters, and set fewer effortful
goals. This ﬁndingwas not replicated in an effort-discounting experimen-
tal task which showed no deﬁcit in people with schizophrenia compared
to controls and no linkwith negative symptoms (Docx et al., 2015). There
is little evidence to suggest that motivation is consistently low in schizo-
phrenia or that there is a difﬁculty identifying goals or desired rewards.
These studies suggest that the problem is in generating and directing
the required effort and actions towards these goals or rewards. The
link between motivation and action would be an important target for a
therapy.
4. Discussion
4.1. Potential therapeutic targets
The most consistent ﬁnding in the reviewed literature is that con-
summatory pleasure is intact in people with schizophrenia. Emotional
memory emerges as an important deﬁcit in people with schizophrenia
with a strong evidence base. Even though the experimental data is
equivocal there is support for deﬁcits in executive functions and build-
ing/maintaining representations contributing to anhedonia in the neu-
roimaging literature using reward-based tasks. Additional ﬁndings
from an experimental task are in line with a deﬁcit in maintaining rep-
resentations over time.
Although there is a strong assumption that neuropsychological task
performance is linked to anhedonia there was no evidence in the litera-
ture for this assumption. It may be that an emotional component in
tasks assessing executive functions is required.
There is preliminary self-report evidence for a speciﬁc anticipatory def-
icit in the context of intact consummatory pleasure in people with schizo-
phrenia which requires replication in an experimental context and daily
life. There is also some indication that individuals with schizophrenia may
have difﬁculty translating motivation into actions towards desired goals.
4.2. Limitations of the current evidence base
In recent years the ﬁeld has moved from assuming a unitary emo-
tional deﬁcit to considering the multiple components involved in
experiencing and anticipating pleasure separately. This approach more
accurately reﬂects both intact pleasure processes and some areas
where people with schizophrenia differ from the general population.
Experimental tasks have focused on consummatory pleasure, a now
well-established intact component, and neglected other processes. Im-
portant avenues of future research are experimental assessments of an-
ticipatory pleasure, representation maintenance and motivation which
would progress our understanding of these processes in people with
schizophrenia and the control population.
There has been extensive use of self-reportmeasures that rely heavi-
ly on retrospective emotionalmemory. This is often impaired in individ-
uals with schizophrenia and future research should focus on using
methodologieswhich avoid such a heavy reliance (Herbener, 2008). Ex-
perience samplingmethodology has shown promise in this ﬁeld and al-
lows a direct measurement of activity levels and pleasure experienced
during everyday life.
It is important to highlight the large number of null ﬁndings in this
review, particularly regarding the links between memory, executive
functions and self-reported anhedonia. This may be due to the small
sample sizes included in the large majority of the studies considered(i.e. average sample size = 40). The majority of studies may therefore
have been under-powered to detect a small-moderate correlation or ef-
fect size. A small-moderate associationmay be expected if the contribu-
tion of executive functions and emotional memory to anticipatory
pleasure is moderated by other factors in the TEPmodel. The replicabil-
ity of the empirical evidence presented in this review is limited by the
sample sizes of the studies included and investigations should be con-
ducted with larger samples to test these hypotheses in the future.
The vast majority of studies used measures of anhedonia similar to
the BPRS and SANS which, as discussed previously, are limited in their
ability to accurately assess anhedonia in people with schizophrenia.
Other studies used the Chapman scaleswhich are designed to assess an-
hedonia the general population. The use of these older scales may also
contribute to the large amount of null ﬁndings in the ﬁeld when exam-
ining relationships with anhedonia as they are not speciﬁc measures of
anticipatory or consummatory pleasure. The use of newer, more specif-
ic, measures would increase the methodological reliability of studies
assessing the TEP model.
4.3. Strengths and limitations
This review met the aim of identifying evidence-based therapeutic
targets among the constructs proposed in the TEPmodel and used strin-
gent PRISMA guidance. A publication bias in the literature is unlikely
given the many studies reporting null ﬁndings as well as positive ﬁnd-
ings for any construct contributing to the experience of anhedonia in
peoplewith schizophrenia. Our conclusions are limited by themeasures
of anhedonia used in themajority of studies, which are non-speciﬁc and
do not reﬂect current thinking in this area. Future studies should
prioritise more speciﬁc measures such as the CAINS and BNSS (Horan
et al., 2011; Kirkpatrick et al., 2011). We did not assess the impact of
co-morbid diagnoses such as substance abuse on emotional experience.
Although studies conducted in many countries including China, Japan,
Hong Kong, Germany, France, The Netherlands and Spain are reviewed,
we may have introduced some bias by excluding those not written in
English, although we do not consider this likely.
4.4. Clinical implications
4.4.1. Emotional memory
If the evidence continues to support a speciﬁc anticipatory pleasure
deﬁcit linked to emotional memory in people with schizophrenia then
psychological therapies could start to target this speciﬁc problem. Treat-
ment studies also allow further tests of the hypotheses set out in the
TEPSmodel. For example an effect on activity as the result of enhancing
anticipatory pleasuremay bemediated bymotivation. Two pilot studies
using Anticipatory Pleasure Skills Training and Broad Minded Affective
Coping (Favrod et al., 2010; Tarrier, 2010) report an improvement in
self-reported anhedonia after treatment but do have very small sample
sizes (n b 10). Both interventions encourage the individual to visualise a
previous similar activity in a relaxed state. They enhance the
multimodality of the anticipation by asking participants to do this
using as many senses as possible. Focusing on the details of a speciﬁc
event limits over-general memory (recalling a general impression of
an activity rather than a speciﬁc event) which may affect the ability to
anticipate pleasure accurately. These therapies build on the individual's
intact experience of pleasure in the moment to give them fuller experi-
ences of remembering that pleasure when anticipating activities in the
future. An advantage of these therapies is that they can easily be
adapted into short training sessionswhich could be administered, in ad-
dition to, or as part of, a comprehensive cognitive and behavioural treat-
ment strategy. Cognitive Remediation Therapy (CRT) (Wykes et al.,
2007) targets memory processes using task-based training and could
also be adapted to enhance emotional memory speciﬁcally. Adding
emotional components to memory tasks or using videos of events
134 C.J. Edwards et al. / Schizophrenia Research 168 (2015) 120–144could help the individual to strengthen the links between their emo-
tions and memories of an event.
4.4.2. Executive functions: creating and maintaining representations
If, as suspected, executive functions contribute to anhedonia, then
Cognitive Remediation Therapy could have a beneﬁcial effect. Available
cognitive training to enhance executive functions could be augmented
to speciﬁcally target anticipating pleasure from future activities e.g.
predicting the details of future events and incorporating emotions. Fur-
ther research to understand the type of cognitive training that could im-
prove reward anticipation is needed. A recent study demonstrated that
CRT can improve reward and punishment sensitivity in people with
schizophrenia (Cella et al., 2013). Changes in this parameter may have
an impact on the anticipatory pleasure experienced and, in turn, reduce
anhedonia. At the very least the current data on cognitive remediation
could be explored for links between improved cognitive function and
anhedonia which can lead to further therapy developments. The ad-
dition of speciﬁc scales in future trials may also allow an investiga-
tion of these links and the development of models of therapeutic
action. For instance reward experienced in therapy might generalise
within therapy to faster learning and also to increased motivation to
carry out tasks in everyday life. The pleasure associated with these
tasks may increase the likelihood that they are repeated because
they build an evidence base for the individual that they can use to
drive future behaviour.
4.4.3. Approach motivation/behaviours
The literature suggests that the low levels of activity reported by in-
dividuals with schizophrenia could be the result of a difﬁculty in trans-
lating motivation into pleasurable activities. This may be the result of a
deﬁcit in planning ability. This is already a target of CRT but the therapy
could be adapted towards enhancing this further and for leisure as well
as functional activities.
Techniques from Cognitive Behavioural Therapy for Psychosis
(CBTp) (Turkington et al., 2006)may improve the process of translating
motivation into action. CBTphas a good evidence base, and although it is
rare for a study to report anhedonia as an outcomemeasure, a few stud-
ies report a general improvement in negative symptoms (but sample
sizes are small) (Rathod et al., 2008). Future research reporting the ef-
fectiveness of adapted CBTp for negative symptoms, such as that devel-
oped byGrant et al. (2012)which reported an improvement in avolition
but not anhedonia, would greatly facilitate the development of therapy.Appendix 1
Reference sample size Negative
symptom
measure
Method
Barch et al.
(2008)
66 SCZ or schizoaffective
disorder/44 healthy
controls.
SANS+Chapman
Scales
Motivational Trait Que
WAIS III Matrix Reaso
Vocabulary, 2-back ve
n-back task, AX versio
tinuous Performance T
Barch et al.
(2014)
59 people with
schizophrenia/39 matched
controls.
SANS, Chapman
Scales, SHAPS,
TEPS.
Effort-expenditure for
Becerril and
Barch (2011)
38 SCZ/32 healthy controls SANS Chapman
Scales
2-Back working memo
emotional faces. fMRI
Berenbaum et al.
(2008)
47 SCZ SANS Verbal and design ﬂue
Working memory taskTherapists using CBTp identify personally relevant goals and use these
to support the client's motivation in therapy. Imagery based techniques
can enhance the vividness and speciﬁcity of the goal and link it to previ-
ous similar events. Asking individuals to record their activities and their
enjoyment of them in a pleasure diary may also be relevant. Deﬁcits in
anticipatory pleasure have also been described in depression (Sherdell
et al., 2012) and a mood diary has been used effectively in Cognitive
Therapy of Depression (Beck, 1979). A pleasure diary could be used to
challenge the belief that the individual experiences low pleasure and
highlights the activities they do ﬁnd enjoyable. An imaginary diary of
their desired activity schedule could also be compared to their real
diary to highlight discrepancies and identify behavioural targets. Explicit-
ly focussing on the cognitive dissonance between forecasted and experi-
enced pleasure and working through this with the individual could
prove beneﬁcial. Mobile technology could be adapted to enhance therapy
by providing amore interactive way of recording emotions and activities.
Such a tool could also provide regular support and encouragement using
real-time information about enjoyable activities.
In conclusion this systematic review identiﬁed several promising
therapeutic targets for emotional and motivational deﬁcits in people
with schizophrenia. The evidence suggests that current therapeutic
practices including CRT, CBTp, mobile technology and imagery/visuali-
sation could be adapted to effectively target the three constructs with
the strongest empirical support (emotional memory, executive func-
tions and approach motivation/behaviours) that may contribute to the
lack of pleasure reported by people with schizophrenia.
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Approach motivation and
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rewards task Individuals with schizophrenia show
lower effort expenditure with
increasing reward or probability than
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associated with more severe negative
symptoms and worse functioning.
Approach motivation and
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ry task with Social anhedonia associated with
diminished responses to emotional
stimuli and increased dorsolateral
prefrontal cortex activity.
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Reference sample size Negative
symptom
measure
Method Findings TEP model construct
span and AX-CPT. Digits forward
subtest of WAIS-R as measure atten-
tion. Lateralised motor performance
task.
memory or attention. Anhedonia did
correlate with lateralised task
performance.
of representation
Berlin et al.
(1998)
20 SCZ/20 major
depression/20 healthy
controls.
Chapman Scales Hedonic responses to sucrose. Hedonic response to sucrose was
inversely correlated with physical
anhedonia.
Consummatory pleasure
Bodapati and
Herbener
(2014)
38 SCZ/53 matched
healthy controls
PANSS In the moment emotional responses
to social and non-social
stimuli—IAPS images.
Control more aroused by social vs.
non-social images—not in SCZ group.
Negative symptom severity predicted
lower arousal responses to unpleas-
ant stimuli.
Consummatory pleasure
Brebion et al.
(1999)
33 SCZ/40 healthy
controls.
SANS Free recall and recognition memory
tasks.
Fewer errors associated with
anhedonia in SCZ group.
Memory
Brebion et al.
(2005)
41 SCZ/43 healthy
controls.
SANS Verbal recognition task. Anhedonia correlated with a reduced
response bias.
Memory
Brebion et al.
(2007a)
41 SCZ/43 healthy
controls.
SANS Temporal context memory task. Anhedonia associated with
signiﬁcantly fewer errors.
Memory
Brebion et al.
(2007b)
41 SCZ SANS Visual memory task—recognition
and spatial memory.
Anhedonia was associated with
response bias, in the opposite
direction from hallucinations
(increased accuracy).
Memory
Brébion et al.,
2010
41 SCZ/43 healthy
controls.
SANS Production of atypical category
exemplars.
Anhedonia signiﬁcantly inversely
correlated with typicality score.
Memory
Brebion et al.
(2012)
41 SCZ/43 healthy
controls.
SANS Source memory, recall and
recognition tasks for words and
pictures.
Verbal, visual and source memory
errors inversely correlated with
anhedonia scores.
Memory
Buck and
Lysaker (2013)
163 SCZ; 52 high
depression/high
anhedonia, 52 low
depression/low
anhedonia, 59 low
depression/high
anhedonia.
PANSS Wisconsin Card Sorting Task,
Metacognition questionnaire,
Bell–Lysaker Emotional Recognition
Task.
No difference between
depression/anhedonia groups in
number of categories correct on the
WCST. High anhedonia/low
depression group had worse
metacognition and social cognition
scores.
Executive functions and
activation/maintenance of
representation
Burbridge and
Barch (2007)
49 SCZ/47 healthy
controls.
Chapman Scales Ratings of emotional stimuli and
tests of working and episodic
memory.
Limited evidence for a link between
working memory and physical
anhedonia. No other associations. No
difference in emotional ratings
between SCZ and controls.
Executive functions and
activation/maintenance of
representation
Chan et al.
(2012)
Anticipatory pleasure
Choi et al (2013) 15 SCZ/17 controls. Chapman Scales,
PANSS.
Participants rated the pleasantness
of both a preview and viewing stage
of a ﬁlm clip. fMRI.
There was no difference between
groups in anticipatory or
consummatory pleasure ratings.
There was reduced activation in the
anterior cingulate cortex during the
preview phase in the SZ group.
Anticipatory pleasure
Cicero et al.
(2014)
54 SCZ/32 controls Chapman Scales Probabilistic Selection Task People with schizophrenia showed a
deﬁcit learning from both positive
and negative feedback. These
persisted even when given extra
trials to learn the reward
contingencies. Neither positive nor
negative reinforcement learning was
associated with anhedonia.
Executive functions and
activation/maintenance of
representation
Cohen and
Minor (2010)
26 studies. N/A Meta-analysis. Patients with SCZ do not differ from
controls when rating their subjective
hedonic experience to stimuli.
Consummatory pleasure
Cohen et al.
(2012)
32 SCZ/25 affective
disorder patients/49 high
positive schizotypy/32
high negative
schizotypy/35 healthy
controls.
SANS Self-reported affective reactions to
neutral, negative and positive
stimuli.
In both schizotypy and schizophrenia
groups negative symptoms were
associated with less pleasant reports.
Consummatory pleasure
Crespo-Facorro
et al. (2001)
18 SCZ/16 healthy controls SANS Studying brain responses to olfactory
stimuli using positron emission
tomography
Patients failed to activate
limbic/paralimbic regions and recruit
a compensatory set of frontal cortical
regions instead. Ratings of anhedonia
did not correlate with blood ﬂow or
pleasantness. scores.
Consummatory pleasure
Demily et al.
(2010)
21 SCZ/20 healthy
controls.
Chapman scales. Emotional Stroop task. Slower RTs in SCZ group. No interac-
tions or associations with anhedonia
scores.
Executive functions and
activation/maintenance of
representation
Dichter et al.
(2010)
16 SCZ/13 matched
controls
SANS Forced-choice visual oddball task.
fMRI
Activation of the anterior cingulate
during the task was inversely
Executive functions and
activation/maintenance of
(continued on next page)
Appendix 1 (continued)
135C.J. Edwards et al. / Schizophrenia Research 168 (2015) 120–144
(continued)
Reference sample size Negative
symptom
measure
Method Findings TEP model construct
correlated with anhedonia. representation
Doop and Park
(2006)
17 SCZ/14 matched
healthy controls.
SANS University of Pennsylvania Smell
identiﬁcation Test (UPSIT)
Pleasantness ratings had a reduced
range in SCZ and positively correlated
with affective ﬂattening but not
anhedonia.
Consummatory pleasure
Docx et al
(2015)
40 SCZ/30 matched
controls
SANS Effort Discounting Task There was no difference between
groups in the effort-discounting
curves. The effort-discounting in the
patient group did not correlate with
symptom measures.
Approach motivation and
behaviours
Dowd and Barch
(2010)
40 SCZ/32 healthy controls SANS Chapman
Scales
Rating valence and arousal to
images. fMRI
Higher anhedonia associated with
reduced activation to positive vs.
negative stimuli in the amygdala and
right ventral striatum in patients.
Consummatory pleasure
Dowd and Barch
(2012)
25 SCZ/20 healthy controls Chapman scales Pavlovian reward prediction
paradigm. fMRI
Group level neural responses to
anticipation and receipt of reward
similar. Individual difference analyses
revealed an association between
physical anhedonia and activity in
the ventral striatum and
ventromedial prefrontal cortex.
Executive functions and
activation/maintenance of
representation
Folley and Park
(2010)
18 SCZ outpatients/18
healthy controls.
SANS Participants indicated which of two
photographs of food they preferred
and gave hedonic ratings of the
pictures.
The use of fewer positive ratings
correlated with increased anhedonia.
SCZ individuals gave more positive
ratings than controls overall.
Consummatory pleasure
Franke et al.
(1994)
35 SCZ/26 healthy
siblings/35 healthy
controls.
Chapman Scales Continuous Performance
Test-Identical Pairs Version
No association found with anhedonia
scores in SCZ group or siblings.
Executive functions and
activation/maintenance of
representation
Gard et al.
(2007)
Study 1: 10 SCZ+5
schizoaffective disorder/12
healthy controls. Study 2:
50 SCZ+1 schizoaffective
disorder/50 healthy
controls.
TEPS Chapman
Scales SANS
Experience Sampling Methodology
Questionnaires
Patients reported similar pleasure
levels to controls during
goal-directed activities but did them
less often. Reduced anticipatory plea-
sure in clinical group on TEPS which
correlated with SANS and Chapman
scales. Intact consummatory
pleasure.
Anticipatory pleasure
Gard et al.
(2011)
28 SZ/19 healthy controls PANSS Emotion maintenance task with a 3 s
delay between the two viewing
phases. Images used.
People with schizophrenia had similar
“in the moment” ratings of pleasure but
reduced positive and negative affect
over the delay period.
Executive functions and
activation/maintenance of
representation
Gard et al.
(2014)
47 SCZ/41 healthy controls PANSS Experience sampling
methodology—current activity and
anticipation of upcoming goals.
These were coded independently for
pleasure and effort. MATRICS battery
People with schizophrenia set fewer
effortful goals and did fewer effortful
activities than controls. They also
showed greater inaccuracy at
estimating the accuracy of goals which
was associated with lower
neurocognition. Compared to controls
people with schizophrenia anticipated
higher pleasure from goals and did
more pleasure-based activities.
Approach motivation and
behaviours
Gold et al.
(2008)
8 studies presented: Patients
with SCZ and demographi-
cally matched controls.
SANS Reward Processing Tasks e.g.
Wisconsin Card-Sorting Task and
responses to IAPS images.
Some modest correlations (.3–.4)
between performance on these tasks
and negative symptoms but most very
low.
Executive functions and
activation/maintenance of
representation
Gradin et al.
(2011)
15 SCZ/15 individuals with
depression/17 healthy
controls.
PANSS Instrumental reward learning task.
fMRI
Reduced prediction error signals
observed in schizophrenia but these did
not correlate with any negative
symptoms.
Executive functions and
activation/maintenance of
representation
Hammer et al.
(1995)
65 SCZ SANS Neuropsychological Tests Anhedonia correlated with
preservative errors on the WCST and
performance on the word ﬂuency and
Trail Making A tasks.
Executive functions and
activation/maintenance of
representation
Harvey et al.
(2009)
29 SCZ/27 matched
healthy controls.
Chapman scales Emotional face recognition memory
involving happy, sad and neutral
expressions.
No difference in pleasure ratings
between controls and people with
SCZ. No correlation between social
anhedonia and memory
performance.
Memory
Harvey et al.
(2010)
30 SCZ/26 healthy controls Chapman Scales Emotional Picture Viewing Task.
fMRI
Anhedonia inversely correlated with
activity in the orbitofrontal cortex
and putamen/ventral striatum in the
patient group.
Consummatory pleasure
Heerey and Gold
(2007)
41 patients with
schizophrenia or
SANS Rate IAPS stimuli for valence and
arousal. Participants could prolong
Patients with SCZ showed weaker
correspondence between their
Approach motivation and
behaviours
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symptom
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Method Findings TEP model construct
schizoaffective disorder/31
healthy controls.
or decrease their exposure to certain
stimuli in one condition and in the
other increase or decrease their like-
lihood of future exposure to a
stimulus.
ratings and their behaviour than
controls.
Herbener et al.
(2007)
33 SCZ/28 healthy
controls.
Chapman Scales Emotional ratings of images then 24
hr delay recognition task.
Higher levels of emotional intensity
in SCZ group. Reduced recognition for
positive images compared to
controls, no difference for negative
images.
Memory
Herbener et al.
(2008)
34 SCZ/35 matched
healthy controls
Chapman Scales Emotional responses to 131 IAPS
images.
Emotional ratings and anhedonia
scores correlated in both groups.
Similar emotional responses in both
groups.
Consummatory pleasure
Horan et al.
(2006)
30 SCZ outpatients/31
healthy controls.
SANS Rated emotional responses to food
and ﬁlm clips then a recall task after
4 hr delay.
No difference between SCZ group and
control group.
Consummatory pleasure
Horan et al.
(2010)
38 SCZ/36 healthy
controls.
Chapman Scales
SANS
Measured event-related potentials
during an affective picture viewing
task.
Higher physical and social anhedonia
was associated with lower valence
ratings for pleasant images. Physical
anhedonia correlated with smaller P2
responses in the unpleasant picture
condition. No other measures of
anhedonia correlated with any other
ERP variables. Higher levels of anhe-
donia correlated with longer viewing
times—more top-down inﬂuences on
emotional processing?
Consummatory pleasure
Juckel et al.
(2006a)
10 SCZ typical
neuroleptics/10 SCZ atypical
neuroleptics/10 matched
controls
PANSS Incentive Monetary Delay Task In patients treated with typical
neuroleptics only reduced activation
in the left ventral striatum was
associated with negative symptoms.
Executive functions and
activation/maintenance of
representation
Juckel et al.
(2006b)
10 SCZ (7 unmedicated, 3
unmedicated for 2
years)/10 healthy controls.
PANSS fMRI during presentation of
reward-predicting and
loss-predicting stimuli in a Monetary
Incentive Delay Task
Left ventral striatal BOLD response
during reward anticipation was in-
versely correlated with PANSS nega-
tive symptom subscale score.
Executive functions and
activation/maintenance of
representation
Kamath et al.
(2011)
54 SCZ/22 unaffected 1st
degree relatives/45
matched healthy controls
SANS Suprathreshold Amyl Acetate Odour
Intensity and Odour Pleasantness
Rating Test
Individuals with schizophrenia
under-estimate pleasure at low con-
centrations and over-estimate it com-
pared to controls at higher
concentrations. This abnormal pattern
correlated with anhedonia/asociality
subscale.
Consummatory pleasure
Kemali et al.
(1987)
21 male SCZ/19 healthy
controls.
SANS Spatial conditional associative
learning task+Non-spatial condi-
tional associative learning task.
No association found between
anhedonia and spatial learning.
Number of errors and time taken in
the non-spatial learning task inverse-
ly correlated with anhedonia scores.
Executive functions and
activation/maintenance of
representation
Lacerda et al.
(2007)
43 ﬁrst-episode,
antipsychotic-naive
SCZ/53 matched controls.
SANS Structural MRI Anhedonia scores correlate with the
volume of the left orbitofrontal
cortex.
Executive functions and
activation/maintenance of
representation
Larquet et al.
(2010)
21 SCZ/10 orbitofrontal
cortex patients/20 healthy
controls.
Chapman Scales Regret Gambling Task No association between anhedonia
and performance on
neuropsychological measures.
Executive functions and
activation/maintenance of
representation
Laurent et al.
(2000)
23 SCZ Outpatients,/47
ﬁrst-degree relatives/34
healthy controls.
Chapman Scales SPAN, DS-CPT, WCST, Digit Symbol,
Trail Making A and B, Stroop task
No associations between
performance and anhedonia in the
SCZ group.
Executive functions and
activation/maintenance of
representation
Lee et al. (2006) 21 SCZ/20 controls PANSS Valence and Arousal ratings to 60
IAPS images.
Similar emotional experience to
controls. No association reported
with anhedonia.
Consummatory pleasure
Lee et al. (2012) 14 SCZ/16 healthy controls Chapman Scales
TEPS
Word-image association encoding
task. fMRI
Activity in hippocampus and nucleus
accumbens when performing
association task correlates with
physical anhedonia scores.
Executive functions and
activation/maintenance of
representation
Llerena et al.
(2012)
26 studies N/A Meta-Analysis of arousal ratings
during stimuli presentation.
Controls and people with
schizophrenia experience similar
arousal levels to unpleasant and
pleasant stimuli. People with
schizophrenia experience more
arousal to neutral stimuli.
Consummatory pleasure
Matsuzawa et al.
(2015)
61 SCZ/50 matched
controls
SANS Iowa Gambling Task People with schizophrenia showed
impaired emotional learning—this
was dependent on the certainty with
which they adopted a strategy for
Executive functions and
activation/maintenance of
representation
(continued on next page)
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positive gain. The deﬁcit in emotional
learning was associated with SANS
anhedonia-asociality subscale scores.
Mote et al.
(2014)
88 people with
recent-onset schizophre-
nia diagnosis/66 controls.
TEPS TEPS administered to examine levels
of anticipatory and consummatory
pleasure in recent-onset group.
People with schizophrenia reported
reduced anticipatory but not
consummatory pleasure compared to
controls.
Anticipatory pleasure
Mucci et al.
(2015)
28 SCZ/22 healthy controls PANSS TEPS
Chapman Physi-
cal Anhedonia
Scale
Monetary Incentive Delay Task. fMRI People with schizophrenia with high
avolition scores showed reduced
dorsal caudate activation compared
to patients with low avolition scores
and controls. This ﬁnding was
repeated for patients with deﬁcit
schizophrenia compared to
non-deﬁcit and controls. Dorsal cau-
date activity was associated with
avolition but not anhedonia in the
patient group.
Executive functions and
activation/maintenance of
representation
Oorschot et al.
(2013)
149 SCZ or schizoaffective
disorder/143 controls.
PANSS Experience Sampling Methodology Patients with high negative
symptoms have similar emotional
experience to controls, low negative
symptom patients more unstable. No
association reported with anhedonia.
Consummatory pleasure
Park et al.
(2009a)
29 SCZ/21 healthy controls Chapman Scales 18 F-ﬂuorodeoxyglucose positron
emission tomography
Physical anhedonia correlated in
resting state activities of the
supplementary motor area,
ventromedial and dorsolateral
prefrontal cortex, insular gyrus and
the precuneus in patients.
Executive functions and
activation/maintenance of
representation
Park et al.
(2009b)
24 SCZ/22 healthy controls Chapman Scales Fluoro-D-glucose positron emission
tomography
Patients with prefrontal
hypofunction showed more severe
anhedonia than those without.
Executive functions and
activation/maintenance of
representation
Park et al.
(2015)
20 SCZ/20 matched
controls
Chapman Scales
PANSS
Deterministic reinforcement
learning task with variable intervals
of contingency reversals fMRI
No difference in positive or negative
reinforcement. Patients showed altered
response valuation and
initiation-related striatal activity and
reduced vACC activation during reward
approach initiation. rACC activation
correlated with social anhedonia and
amotivation.
Executive functions and
activation/maintenance of
representation
Quirk et al.
(1998)
30 SCZ/10 controls PANSS Rating valence and arousal to 54 IAPS
images.
Average valence slightly lower in SCZ
group. No association with
anhedonia.
Consummatory pleasure
Roux et al.
(2010)
21 patients with SCZ/21
healthy controls.
Chapman Scales Explicit recognition task and Vocal
emotional Stroop task.
Vocal emotional stroop score
increased with social anhedonia.
Executive functions and
activation/maintenance of
representation
Sanchez et al,
2014
47 SCZ/41 healthy controls PANSS Experience sampling
methodology—ratings of mood and
enjoyment of current activity.
MATRICS neurocognitive battery.
People with schizophrenia had
higher negative mood but similar
positive mood and enjoyment to
controls. People with schizophrenia
had a weaker relationship between
negative mood and current
enjoyment of activities compared to
controls. Neurocognitive scores
mediated this relationship in people
with schizophrenia.
Consummatory pleasure
Schlagenhauf
et al. (2008)
10 SCZ on typical neuro-
leptics then again once
switched Olanzapine/10
matched controls.
PANSS Monetary Incentive Delay Task. fMRI In patients treated with typical
neuroleptics decreased left ventral
striatal activation was correlated
with negative symptoms.
Executive functions and
activation/maintenance of
representation
Schlenker et al.
(1995)
34 male SCZ/24 male
healthy controls.
Chapman Scales Startle-elicited brinks measured dur-
ing presentation of affective slides.
No difference in patients and controls
in subjective or autonomic response
to slides. No associations with
anhedonia.
Consummatory pleasure
Schneider et al.
(1995)
40 SCZ/40 Controls SANS Emotion discrimination tasks and
mood induction procedures.
Negative correlation present between
mood induction scores and
anhedonia subscale. No correlation
between anhedonia and emotion
discrimination.
Consummatory pleasure
Simon et al.
(2010)
15 SCZ/15 healthy controls Chapman Scales Probabilistic Monetary Incentive
Delay Task. fMRI
No signiﬁcant differences at group
level in anticipation or receipt of
reward. No associations with
anhedonia scales.
Executive functions and
activation/maintenance of
representation
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Stevens et al.
(2002)
25 SCZ treated with
olanzapine, 25 SCZ treated
with classic neuroleptics,
25 matched controls.
SANS and SHAPS. Serial Reaction Tim task, Classic
Eye-Blink Conditioning and Explicit
Visuospatial Memory Task
No associations with anhedonia. Memory
Strauss and
Herbener
(2011)
49 outpatients with
SCZ/50 healthy controls.
Chapman Scales Rating IAPS images on valence and
arousal scales.
60% rated similarly to controls, 40%
showed an atypical proﬁle.
Consummatory pleasure
Strauss et al.
(2011a)
51 outpatients with
SCZ/39 healthy controls.
SANS Temporal decision-making
task—requiring trial-by-trial adjust-
ment to maximise reward. Go NoGo
Task.
Individuals with high negative
symptoms showed more impairment
on Go NoGo than those with low
negative symptoms.
Uncertainty-based exploration was
reduced compared to controls and
correlated with anhedonia.
Executive functions and
activation/maintenance of
representation
Strauss et al.
(2011b)
38 SCZ/27 healthy
controls.
SANS Subjects presented with pairs of
positive stimuli and asked to indicate
which they preferred.
Less differentiation between the
valence levels but same pattern of
results.
Consummatory PLEASURE
Strauss et al.
(2014)
97 SCZ/63 healthy
controls.
SANS, Chapman
Scales
Victoria Symptom Validity Test to
measure effort. WTAR and MATRICS
cognitive tests.
Global neurocognitive impairment
predicted by low effort and negative
symptoms.
Executive functions and
activation/maintenance of
representation
Suslow et al.
(1998)
31 SCZ (predominantly
negative symptoms)
SANS Visual backward masking task, Span
of Apprehension task, WCST and de-
graded stimulus Continuous Perfor-
mance Test.
Card sorting preservative errors
correlated with negatively with
anhedonia. No other associations
with anhedonia found.
Executive functions and
activation/maintenance of
representation
Szendi et al.
(2006)
13 male SCZ/13 male
controls
SANS Structural MRI +Working Memory
Tasks
Anhedonia negatively correlated
with the relative volume of the left
straight gyrus. No group differences
in regions of interest. Anhedonia
correlated with performance on the
Tower of Hanoi and Corsi Blocks
Backwards tasks.
Executive functions and
activation/maintenance of
representation
Trémeau et al.
(2009)
64 SCZ/32 healthy
controls.
Chapman Scales Evocative emotional task with
pictures, sounds and words of
varying valence and
intensity—participants rated
pleasantness and arousal.
Ambivalence to positive stimuli
correlated with anhedonia in SCZ.
Consummatory pleasure
Trémeau et al.
(2010)
70 SCZ/35 controls SANS Rating pleasantness and arousal in
an evocative emotional task using
pictures, sounds and words. Also
rating pre-test anticipated pleasure
and post-test remembered pleasure.
Emotional experience and
anticipated pleasure was similar in
both group. Remembered pleasure
was higher in SCZ group. Anticipatory
pleasure correlated with SANS total
but not anhedonia.
Anticipatory pleasure
Trémeau et al.
(2014)
Anticipatory pleasure
Ursu et al.
(2011)
23 SCZ/24 healthy
controls.
SANS Reporting emotional response to
IAPS images after a short delay. fMRI.
Same brain activity in both groups
when presented with images. During
the delay after pleasant images
reduced activation in the dorsolateral
prefrontal cortex in patient group
was seen which correlated with
anhedonia.
Executive functions and
activation/maintenance of
representation
Walter et al.
(2009)
16 SCZ/16 healthy
controls.
Chapman Scales fMRI during a delayed incentive
paradigm with monetary rewards.
Dorsal anterior cingulated activation
reduced in patient group in
expectation phase but no correlations
with negative symptom or anhedonia
scores.
Executive functions and
activation/maintenance of
representation
Walter et al.
(2010)
Study 1:16 SCZ/16 controls
Study2: 12 SCZ/12 controls
Chapman Scales Financial Reward Task Aberrant salience coding seen in the
ventromedial prefrontal cortex of
patients with schizophrenia, the
degree of this salience coding was
inversely correlated with anhedonia
scores.
Executive functions and
activation/maintenance of
representation
Waltz and Gold
(2007)
34 SCZ/26 controls. SANS Probabilistic reversal learning task. SCZ group worse at reversal learning
but this did not correlate with
anhedonia or negative symptoms.
Executive functions and
activation/maintenance of
representation
Waltz et al.
(2009)
18 SCZ/18 healthy controls Chapman Scales Passive conditioning task. fMRI Group differences generally driven by
attenuated responses in patient
group to positive temporal difference
errors (unexpected juice deliveries).
No associations reported with
anhedonia scores.
Executive functions and
activation/maintenance of
representation
Waltz et al.
(2010)
17 SCZ/17 matched
controls.
SANS Chapman
Scales
fMRI during monetary incentive
delay task.
Signiﬁcant correlation between
activity in the right ventral striatum
when viewing a cue predicting
reward and anhedonia scores.
Executive functions and
activation/maintenance of
representation
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Negative symptoms correlate with
prefrontal cortex activity in response
to gains and losses.
Waltz et al, 2015 42 SCZ/44 healthy controls Chapman Scales
SANS BNSS
Sensory-speciﬁc satiety paradigm. Control participants showed an effect
of satiety that was sensory-speciﬁc,
whereas people with schizophrenia
did not. Satiety effects correlated
with positive and negative symptoms
(Chapman physical and social scales
and SANS anheodnia/avolition) in the
schizophrenia group.
Executive functions and
activation/maintenance of
representation
Woodruff et al.
(1997)
Full sample: 42 SCZ/43
healthy controls. Stroop
task subsample: 27 SCZ/29
healthy controls
SANS Structural MRI and modiﬁed Stroop
Task
Negative correlation between
anterior corpus callosum area and
anhedonia scores. No association
reported for Stroop task performance
and anhedonia.
Executive functions and
activation/maintenance of
representation
Wynn et al.
(2010)
34 SCZ/36 healthy controls Chapman scales.
SANS TEPS
Event related potentials (ERPs) and
emotional responses whilst viewing
images.
Similar patterns of emotional
response in both groups. Lower ERPs
in patient group. No association
between ERP and anhedonia
reported.
Consummatory pleasure
Yan et al. (2012) 21 studies state arousal/40
studies state valence/47
studies trait hedonic
capacity.
N/A Meta-analysis No difference between controls and
SCZ in state valence or arousal, lower
trait hedonic capacity in SCZ group.
Negative symptoms were a signiﬁ-
cant moderator for the effect size for
trait hedonic capacity.
Consummatory pleasure
Appendix 1 (continued)
140 C.J. Edwards et al. / Schizophrenia Research 168 (2015) 120–144
141C.J. Edwards et al. / Schizophrenia Research 168 (2015) 120–144Appendix 2Title 1 Identify the report as a systematic review, meta-analysis, or both. 1
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number. 
1
Rationale 3 Describe the rationale for the review in the context of what is already known. 2
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS). 
2
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number. 
N/A
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale. 
2
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched. 
2
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated. 
2
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis). 
2
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators. 
2
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made. 
2
Risk of bias in individual 
studies 
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis. 
2
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). N/A
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I2) for each meta-analysis. 
N/A
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies). 
2
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified. 
N/A
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram. 
Figure 2
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations. 
Appendix 
1
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). Appendix 
1
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. 
N/A
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency. N/A
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see item 15). 15
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see item 16]). N/A
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers). 
14
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias). 
15
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research. 14/15
Funding 27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review. 
16
Title
Abstract
Introduction
Methods
Results
Discussion
Funding
142 C.J. Edwards et al. / Schizophrenia Research 168 (2015) 120–144References
American Psychiatric Association, 2013. Diagnostic and statistical manual of mental disor-
ders (Washington, DC).
Andreasen, 1982. Negative symptoms in schizophrenia. Deﬁnition and reliability. Arch.
Gen. Psychiatry 39 (7), 784–788.
Barch, D.M., Treadway, M.T., Schoen, N., 2014. Effort, anhedonia, and function in schizo-
phrenia: reduced effort allocation predicts amotivation and functional impairment.
J. Abnorm. Psychol. 123 (2), 387–397.
Barch, D.M., Yodkovik, N., Sypher-Locke, H., Hanewinkel, M., 2008. Intrinsic motivation in
schizophrenia: relationships to cognitive function, depression, anxiety, and personal-
ity. J. Abnorm. Psychol. 117 (4), 776–787.
Becerril, K., Barch, D., 2011. Inﬂuence of emotional processing on working memory in
schizophrenia. Schizophr. Bull. 37 (5), 1027–1038 (Epub 2010 Feb 1022).
Beck, A.T., 1979. Cognitive Therapy of Depression. Guilford Press.
Berenbaum, H., Kerns, J.G., Vernon, L.L., Gomez, J.J., 2008. Cognitive correlates of schizo-
phrenia signs and symptoms: II. Emotional disturbances. Psychiatry Res. 159 (1-2),
157–162 (Epub 2008 Apr 2018).
Berlin, I., Givry-Steiner, L., Lecrubier, Y., Puech, A.J., 1998. Measures of anhedonia and he-
donic responses to sucrose in depressive and schizophrenic patients in comparison
with healthy subjects. Eur. Psychiatry 13 (6), 303–309.
Blanchard, J.J., Bellack, A.S., Mueser, K.T., 1994. Affective and social-behavioral correlates
of physical and social anhedonia in schizophrenia. J. Abnorm. Psychol. 103 (4),
719–728.
Bodapati, A.S., Herbener, E.S., 2014. The impact of social content and negative symptoms
on affective ratings in schizophrenia. Psychiatry Res. 218 (1–2), 25–30.
Brebion, G., Amador, X., Smith, M.J., Malaspina, D., Sharif, Z., Gorman, J.M., 1999. Opposite
links of positive and negative symptomatologywith memory errors in schizophrenia.
Psychiatry Res. 88 (1), 15–24.
Brebion, G., Bressan, R.A., Ohlsen, R.I., Pilowsky, L.S., David, A.S., 2010. Production of atyp-
ical category exemplars in patients with schizophrenia. J. Int. Neuropsychol. Soc. 16
(5), 822–828 (Epub 2010 Jul 2018).
Brebion, G., David, A.S., Ohlsen, R., Jones, H.M., Pilowsky, L.S., 2007. Visual memory
errors in schizophrenic patients with auditory and visual hallucinations. J. Int.
Neuropsychol. Soc. 13 (5), 832–838.
Brebion, G., Ohlsen, R.I., Bressan, R.A., David, A.S., 2012. Source memory errors in schizo-
phrenia, hallucinations and negative symptoms: a synthesis of research ﬁndings.
Psychol. Med. 42 (12), 2543–2554. http://dx.doi.org/10.1017/S003329171200075X
(Epub 003329171202012 Apr 003329171200027).
Buck, B., Lysaker, P.H., 2013. Consummatory and anticipatory anhedonia in schizophrenia:
Stability, and associations with emotional distress and social function over six
months. Psychiatry Res. 205 (1–2), 30–35.
Burbridge, J.A., Barch, D.M., 2007. Anhedonia and the experience of emotion in individuals
with schizophrenia. J. Abnorm. Psychol. 116 (1), 30–42.
Cella, M., Bishara, A.J., Medin, E., Swan, S., Reeder, C., Wykes, T., 2013. Identifying Cognitive
Remediation Change Through Computational Modelling–Effects on Reinforcement
Learning in Schizophrenia. Schizophr. Bull.
Chan, R.C., Shi, Y.F., Lai, M.K., Wang, Y.N., Wang, Y., Kring, A.M., 2012. The Temporal Expe-
rience of Pleasure Scale (TEPS): exploration and conﬁrmation of factor structure in a
healthy Chinese sample. PLoS One 7 (4), e35352.
Chapman, L.J., Chapman, J.P., Raulin, M.L., 1976. Scales for physical and social anhedonia.
J. Abnorm. Psychol. 85 (4), 374–382.
Choi, S.-H., Lee, H., Ku, J., Yoon, K.J., Kim, J.-J., 2013. Neural basis of anhedonia as a failure to
predict pleasantness in schizophrenia. World J. Biol. Psychiatry 1–9.
Cicero, D.C., Martin, E.A., Becker, T.M., Kerns, J.G., 2014. Reinforcement learning deﬁcits in
people with schizophrenia persist after exten\ded trials. Psychiatry Res. 220 (3),
760–764.
Cohen, A.S., Callaway, D.A., Najolia, G.M., Larsen, J.T., Strauss, G.P., 2012. On "risk" and re-
ward: investigating state anhedonia in psychometrically deﬁned schizotypy and
schizophrenia. J. Abnorm. Psychol. 121 (2), 407–415 (Epub 2011 Dec 2012).
Cohen, A.S., Minor, K.S., 2010. Emotional experience in patients with schizophrenia
revisited: meta-analysis of laboratory studies. Schizophr. Bull. 36 (1), 143–150
(Epub 2008 Jun 2017).
Cohen, A.S., Najolia, G.M., Brown, L.A., Minor, K.S., 2011. The state-trait disjunction of an-
hedonia in schizophrenia: potential affective, cognitive and social-based mecha-
nisms. Clin. Psychol. Rev. 31 (3), 440–448 (Epub 2010 Nov 2012).
Crespo-Facorro, B., Paradiso, S., Andreasen, N.C., O'Leary, D.S., Watkins, G.L., Ponto, L.L.,
Hichwa, R.D., 2001. Neural mechanisms of anhedonia in schizophrenia: a PET study
of response to unpleasant and pleasant odors. JAMA 286 (4), 427–435.
Demily, C., Attala, N., Fouldrin, G., Czernecki, V., Menard, J.F., Lamy, S., Dubois, B., Thibaut,
F., 2010. The Emotional Stroop task: a comparison between schizophrenic subjects
and controls. Eur. Psychiatry 25 (2), 75–79 (Epub 2009 Jun 2021).
Dichter, G.S., Bellion, C., Casp, M., Belger, A., 2010. Impaired modulation of attention
and emotion in schizophrenia. Schizophr. Bull. 36 (3), 595–606 (Epub 2008 Oct
2008).
Docx, L., de la Asuncion, J., Sabbe, B., Hoste, L., Baeten, R.,Warnaerts, N., Morrens, M., 2015.
Effort discounting and its association with negative symptoms in schizophrenia.
Cogn. Neuropsychiatry 20 (2), 172–185.
Dollfus, S., Petit, M., 1995. Stability of positive and negative symptoms in schizophrenic
patients: a 3-year follow-up study. Eur. Psychiatry 10 (5), 228–236.
Doop, M.L., Park, S., 2006. On knowing and judging smells: identiﬁcation and hedonic
judgment of odors in schizophrenia. Schizophr. Res. 81 (2-3), 317–319 (Epub 2005
Sep 2021).
Dowd, E.C., Barch, D.M., 2010. Anhedonia and emotional experience in schizophrenia:
neural and behavioral indicators. Biol. Psychiatry 67( (10), 902–911 (Epub 2009
Dec 2009).Dowd, E.C., Barch, D.M., 2012. Pavlovian reward prediction and receipt in schizo-
phrenia: relationship to anhedonia. PLoS One 7 (5), e35622 (Epub 32012 May
35624).
Elis, O., Caponigro, J.M., Kring, A.M., 2013. Psychosocial treatments for negative symptoms
in schizophrenia: current practices and future directions. Clin. Psychol. Rev. 33 (8),
914–928.
Esslinger, C., Englisch, S., Inta, D., Rausch, F., Schirmbeck, F., Mier, D., Kirsch, P., Meyer-
Lindenberg, A., Zink, M., 2012. Ventral striatal activation during attribution of stimu-
lus saliency and reward anticipation is correlated in unmedicated ﬁrst episode
schizophrenia patients. Schizophr. Res. 140 (1-3), 114–121.
Favrod, J., Giuliani, F., Ernst, F., Bonsack, C., 2010. Anticipatory pleasure skills training: a
new intervention to reduce anhedonia in schizophrenia. Perspect. Psychiatr. Care
46 (3), 171–181.
Folley, B.S., Park, S., 2010. Relative food preference and hedonic judgments in schizophre-
nia. Psychiatry Res. 175 (1-2), 33–37 (Epub 2009 Nov 2020).
Foussias, G., Mann, S., Zakzanis, K.K., van Reekum, R., Agid, O., Remington, G., 2011. Predic-
tion of longitudinal functional outcomes in schizophrenia: the impact of baseline mo-
tivational deﬁcits. Schizophr. Res. 132 (1), 24–27 (Epub 2011 Jul 2019).
Franke, P., Maier, W., Hardt, J., Hain, C., Cornblatt, B.A., 1994. Attentional abilities andmea-
sures of schizotypy: their variation and covariation in schizophrenic patients, their
siblings, and normal control subjects. Psychiatry Res. 54 (3), 259–272.
Frederickson, B.L., 2001. The Role of Positive Emotions in Positive Psychology: The Broad-
en-and-Build Theory of Positive Emotions. Am. Psychol. 56 (3), 218–226.
Fusar-Poli, P., Papanastasiou, E., Stahl, D., Rocchetti, M., Carpenter, W., Shergill, S.,
McGuire, P., 2014. Treatments of Negative Symptoms in Schizophrenia: Meta-Analy-
sis of 168 Randomized Placebo-Controlled Trials. Schizophr. Bull.
Gard, D.E., Cooper, S., Fisher, M., Genevsky, A., Mikels, J.A., Vinogradov, S., 2011. Evidence
for an emotion maintenance deﬁcit in schizophrenia. Psychiatry Res. 187 (1-2),
24–29.
Gard, D.E., Gard, M.G., Kring, A.M., John, O.P., 2006. Anticipatory and consummatory com-
ponents of the experience of pleasure: a scale development study. J. Res. Pers. 40 (6),
1086–1102.
Gard, D.E., Kring, A.M., Gard, M.G., Horan, W.P., Green, M.F., 2007. Anhedonia in schizo-
phrenia: distinctions between anticipatory and consummatory pleasure. Schizophr.
Res. 93 (1-3), 253–260 (Epub 2007 May 2009).
Gard, D.E., Sanchez, A.H., Cooper, K., Fisher, M., Garrett, C., Vinogradov, S., 2014. Do people
with schizophrenia have difﬁculty anticipating pleasure, engaging in effortful behav-
ior, or both? J. Abnorm. Psychol. 123 (4), 771–782.
Gelber, E.I., Kohler, C.G., Bilker, W.B., Gur, R.C., Brensinger, C., Siegel, S.J., Gur, R.E., 2004.
Symptom and demographic proﬁles in ﬁrst-episode schizophrenia. Schizophr. Res.
67 (2-3), 185–194.
Gold, J.M., Waltz, J.A., Prentice, K.J., Morris, S.E., Heerey, E.A., 2008. Reward processing in
schizophrenia: a deﬁcit in the representation of value. Schizophr. Bull. 34 (5),
835–847 (Epub 2008 Jun 2030).
Gradin, V.B., Kumar, P., Waiter, G., Ahearn, T., Stickle, C., Milders, M., Reid, I., Hall, J., Steele,
J.D., 2011. Expected value and prediction error abnormalities in depression and
schizophrenia. Brain 134 (Pt 6), 1751–1764 (Epub 2011 Apr 1710).
Grant, P.M., Huh, G.A., Perivoliotis, D., Stolar, N.M., Beck, A.T., 2012. Randomized trial to
evaluate the efﬁcacy of cognitive therapy for low-functioning patients with schizo-
phrenia. Arch. Gen. Psychiatry 69 (2), 121–127. http://dx.doi.org/10.1001/
archgenpsychiatry.2011.1129 (Epub 2011 Oct 1003).
Hammer, M.A., Katsanis, J., Iacono, W.G., 1995. The relationship between negative symp-
toms and neuropsychological performance. Biol. Psychiatry 37 (11), 828–830.
Harvey, P.O., Armony, J., Malla, A., Lepage, M., 2010. Functional neural substrates of self-
reported physical anhedonia in non-clinical individuals and in patients with schizo-
phrenia. J. Psychiatr. Res. 44 (11), 707–716 (Epub 2010 Jan 2029).
Harvey, P.O., Bodnar, M., Sergerie, K., Armony, J., Lepage, M., 2009. Relation between emo-
tional face memory and social anhedonia in schizophrenia. J. Psychiatry Neurosci. 34
(2), 102–110.
Heerey, E.A., Gold, J.M., 2007. Patients with schizophrenia demonstrate dissociation be-
tween affective experience and motivated behavior. J. Abnorm. Psychol. 116 (2),
268–278.
Heinz, A., Knable, M.B., Coppola, R., Gorey, J.G., Jones, D.W., Lee, K.S., Weinberger, D.R.,
1998. Psychomotor slowing, negative symptoms and dopamine receptor availabili-
ty–an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients.
Schizophr. Res. 31 (1), 19–26.
Herbener, E.S., 2008. Emotional memory in schizophrenia. Schizophr. Bull. 34 (5),
875–887.
Herbener, E.S., Rosen, C., Khine, T., Sweeney, J.A., 2007. Failure of positive but not negative
emotional valence to enhance memory in schizophrenia. J. Abnorm. Psychol. 116 (1),
43–55.
Herbener, E.S., Song, W., Khine, T.T., Sweeney, J.A., 2008. What aspects of emotional func-
tioning are impaired in schizophrenia? Schizophr. Res. 98 (1-3), 239–246 (Epub 2007
Aug 2003).
Horan, W.P., Blanchard, J.J., 2003. Neurocognitive, social, and emotional dysfunction in
deﬁcit syndrome schizophrenia. Schizophr. Res. 65 (2-3), 125–137.
Horan, W.P., Green, M.F., Kring, A.M., Nuechterlein, K.H., 2006. Does anhedonia in schizo-
phrenia reﬂect faulty memory for subjectively experienced emotions? J. Abnorm.
Psychol. 115 (3), 496–508.
Horan, W.P., Kring, A.M., Gur, R.E., Reise, S.P., Blanchard, J.J., 2011. Development and psy-
chometric validation of the Clinical Assessment Interview for Negative Symptoms
(CAINS). Schizophr. Res. 132 (2-3), 140–145. http://dx.doi.org/10.1016/j.schres.
2011.1006.1030 (Epub 2011 Jul 1027).
Horan, W.P., Wynn, J.K., Kring, A.M., Simons, R.F., Green, M.F., 2010. Electrophysiological
correlates of emotional responding in schizophrenia. J. Abnorm. Psychol. 119 (1),
18–30.
143C.J. Edwards et al. / Schizophrenia Research 168 (2015) 120–144Juckel, G., Schlagenhauf, F., Koslowski,M., Filonov, D.,Wustenberg, T., Villringer, A., Knutson,
B., Kienast, T., Gallinat, J., Wrase, J., Heinz, A., 2006a. Dysfunction of ventral striatal
reward prediction in schizophrenic patients treated with typical, not atypical, neuro-
leptics. Psychopharmacology (Berl.) 187 (2), 222–228 (Epub 2006 May 2024).
Juckel, G., Schlagenhauf, F., Koslowski, M., Wustenberg, T., Villringer, A., Knutson, B.,
Wrase, J., Heinz, A., 2006b. Dysfunction of ventral striatal reward prediction in schizo-
phrenia. NeuroImage 29 (2), 409–416.
Kamath, V., Moberg, P.J., Kohler, C.G., Gur, R.E., Turetsky, B.I., 2011. Odor Hedonic Capacity
and Anhedonia in Schizophrenia and Unaffected First-Degree Relatives of Schizo-
phrenia Patients. Schizophr. Bull. 26, 26.
Kay, S.R., Fiszbein, A., Opler, L.A., 1987. The positive and negative syndrome scale (PANSS)
for schizophrenia. Schizophr. Bull. 13 (2), 261–276.
Kemali, D., Maj, M., Galderisi, S., Monteleone, P., Mucci, A., 1987. Conditional associative
learning in drug-free schizophrenic patients. Neuropsychobiology 17 (1-2), 30–34.
Kirkpatrick, B., Fenton, W.S., Carpenter Jr., W.T., Marder, S.R., 2006. The NIMH-MATRICS
consensus statement on negative symptoms. Schizophr. Bull. 32 (2), 214–219
(Epub 2006 Feb 2015).
Kirkpatrick, B., Strauss, G.P., Nguyen, L., Fischer, B.A., Daniel, D.G., Cienfuegos, A., Marder,
S.R., 2011. The brief negative symptom scale: psychometric properties. Schizophr.
Bull. 37 (2), 300–305 (Epub 2010 Jun 2017).
Kirsch, P., Ronshausen, S., Mier, D., Gallhofer, B., 2007. The inﬂuence of antipsychotic
treatment on brain reward system reactivity in schizophrenia patients.
Pharmacopsychiatry 40 (5), 196–198.
Kring, A.M., Barch, D.M., 2014. The motivation and pleasure dimension of negative symp-
toms: Neural substrates and behavioral outputs. Eur. Neuropsychopharmacol. 24 (5),
725–736.
Kring, A.M., Caponigro, J.M., 2010. Emotion in Schizophrenia Where Feeling Meets Think-
ing. Curr. Dir. Psychol. Sci. 19 (4), 255–259.
Krupa, T., Thornton, J.P., 1986. The Pleasure Deﬁcit in Schizophrenia. Occup. Ther. Ment.
Health 6 (2), 65–78.
Lacerda, A.L., Hardan, A.Y., Yorbik, O., Vemulapalli, M., Prasad, K.M., Keshavan, M.S., 2007.
Morphology of the orbitofrontal cortex in ﬁrst-episode schizophrenia: relationship
with negative symptomatology. Prog. Neuropsychopharmacol. Biol. Psychiatry 31
(2), 510–516 (Epub 2007 Jan 2018).
Lang, P.J., Bradley, M.M., Cuthbert, B.N., 1999. International affective picture system
(IAPS): technical manual and affective ratings. The Center for Research in Psycho-
physiology, University of Florida, Gainesville, FL.
Larquet, M., Coricelli, G., Opolczynski, G., Thibaut, F., 2010. Impaired decision making in
schizophrenia and orbitofrontal cortex lesion patients. Schizophr. Res. 116 (2-3),
266–273.
Laurent, A., Biloa-Tang, M., Bougerol, T., Duly, D., Anchisi, A.M., Bosson, J.L., Pellat, J.,
d'Amato, T., Dalery, J., 2000. Executive/attentional performance and measures of
schizotypy in patients with schizophrenia and in their nonpsychotic ﬁrst-degree rel-
atives. Schizophr. Res. 46 (2-3), 269–283.
Lee, E., Kim, J.J., Namkoong, K., An, S.K., Seok, J.H., Lee, Y.J., Kang, J.I., Choi, J.H., Hong, T.,
Jeon, J.H., Lee, H.S., 2006. Aberrantly ﬂattened responsivity to emotional pictures in
paranoid schizophrenia. Psychiatry Res. 143 (2-3), 135–145 (Epub 2006 Aug 2001).
Lee, J.S., Chun, J.W., In Kang, J., Kang, D.I., Park, H.J., Kim, J.J., 2012. Hippocampus and nu-
cleus accumbens activity during neutral word recognition related to trait physical an-
hedonia in patients with schizophrenia: An fMRI study. Psychiatry Res. 203 (1),
46–53. http://dx.doi.org/10.1016/j.pscychresns.2011.1009.1004 (Epub 2012 Aug
1014).
Llerena, K., Strauss, G.P., Cohen, A.S., 2012. Looking at the other side of the coin: a meta-
analysis of self-reported emotional arousal in people with schizophrenia. Schizophr.
Res. 142 (1-3), 65–70.
Loas, G., Monestes, J.L., Ingelaere, A., Noisette, C., Herbener, E.S., 2009. Stability and rela-
tionships between trait or state anhedonia and schizophrenic symptoms in schizo-
phrenia: a 13-year follow-up study. Psychiatry Res. 166 (2-3), 132–140 (Epub 2009
Mar 2009).
Matsuzawa, D., Shirayama, Y., Niitsu, T., Hashimoto, K., Iyo, M., 2015. Deﬁcits in emotion
based decision-making in schizophrenia; a new insight based on the Iowa Gambling
Task. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 57, 52–59.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., The Prisma Group, 2009. Preferred
Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.
PLoS Med. 6 (7), e1000097.
Morris, R.W., Vercammen, A., Lenroot, R., Moore, L., Langton, J.M., Short, B., Kulkarni, J.,
Curtis, J., O'Donnell, M., Weickert, C.S., Weickert, T.W., 2012. Disambiguating ventral
striatum fMRI-related BOLD signal during reward prediction in schizophrenia. Mol.
Psychiatry 17 (3), 235 (280-239).
Mote, J., Minzenberg, M.J., Carter, C.S., Kring, A.M., 2014. Deﬁcits in anticipatory but not
consummatory pleasure in people with recent-onset schizophrenia spectrum disor-
ders. Schizophr. Res. 159 (1), 76–79.
Mucci, A., Dima, D., Soricelli, A., Volpe, U., Bucci, P., Frangou, S., Prinster, A., Salvatore, M.,
Galderisi, S., Maj, M., 2015. Is avolition in schizophrenia associated with a deﬁcit of
dorsal caudate activity? A functional magnetic resonance imaging study during re-
ward anticipation and feedback. Psychol. Med. 1–14.
Murray, G.K., Corlett, P.R., Clark, L., Pessiglione, M., Blackwell, A.D., Honey, G., Jones, P.B.,
Bullmore, E.T., Robbins, T.W., Fletcher, P.C., 2008. Substantia nigra/ventral tegmental
reward prediction error disruption in psychosis. Mol. Psychiatry 13 (3), 239 (267-
276).
Oorschot, M., Lataster, T., Thewissen, V., Lardinois, M., Wichers, M., van Os, J., Delespaul, P.,
Myin-Germeys, I., 2013. Emotional Experience in Negative Symptoms of Schizophre-
nia–No Evidence for a Generalized Hedonic Deﬁcit. Schizophr. Bull. 20, 20.
Park, I.H., Chun, J.W., Park, H.-J., Koo, M.-S., Park, S., Kim, S.-H., Kim, J.-J., 2015. Altered
cingulo-striatal function underlies reward drive deﬁcits in schizophrenia. Schizophr.
Res. 161 (2–3), 229–236.Park, K.M., Kim, J.J., Seok, J.H., Chun, J.W., Park, H.J., Lee, J.D., 2009. Anhedonia and ambiv-
alence in schizophrenic patients with fronto-cerebellar metabolic abnormalities: a
ﬂuoro-d-glucose positron emission tomography study. Psychiatry Investig. 6 (2),
72–77 (Epub 2009 Jun 2030).
Quirk, S.W., Strauss, M.E., Sloan, D.M., 1998. Emotional response as a function of symp-
toms in schizophrenia. Schizophr. Res. 32 (1), 31–39.
Rathod, S., Kingdon, D., Weiden, P., Turkington, D., 2008. Cognitive-behavioral therapy for
medication-resistant schizophrenia: a review. J. Psychiatr. Pract. 14 (1), 22–33.
Rocca, P., Montemagni, C., Zappia, S., Piterà, R., Sigaudo, M., Bogetto, F., 2014. Negative
symptoms and everyday functioning in schizophrenia: a cross-sectional study in a
real world-setting. Psychiatry Res. 218 (3), 284–289.
Roux, P., Christophe, A., Passerieux, C., 2010. The emotional paradox: dissociation be-
tween explicit and implicit processing of emotional prosody in schizophrenia.
Neuropsychologia 48 (12), 3642–3649 (Epub 2010 Aug 3627).
Sanchez, A.H., Lavaysse, L.M., Starr, J.N., Gard, D.E., 2014. Daily life evidence of environ-
ment-incongruent emotion in schizophrenia. Psychiatry Res. 220 (1-2), 89–95.
Schlagenhauf, F., Juckel, G., Koslowski, M., Kahnt, T., Knutson, B., Dembler, T., Kienast, T.,
Gallinat, J., Wrase, J., Heinz, A., 2008. Reward system activation in schizophrenic pa-
tients switched from typical neuroleptics to olanzapine. Psychopharmacology
(Berl.) 196 (4), 673–684 (Epub 2007 Dec 2021).
Schlenker, R., Cohen, R., Hopmann, G., 1995. Affective modulation of the startle reﬂex in
schizophrenic patients. Eur. Arch. Psychiatry Clin. Neurosci. 245 (6), 309–318.
Schmidt, K., Nolte-Zenker, B., Patzer, J., Bauer, M., Schmidt, L.G., Heinz, A., 2001. Psycho-
pathological correlates of reduced dopamine receptor sensitivity in depression,
schizophrenia, and opiate and alcohol dependence. Pharmacopsychiatry 34 (2),
66–72.
Schneider, F., Gur, R.C., Gur, R.E., Shtasel, D.L., 1995. Emotional processing in schizophre-
nia: Neurobehavioral probes in relation to psychopathology. Schizophr. Res. 17 (1),
67–75.
Sherdell, L., Waugh, C.E., Gotlib, I.H., 2012. Anticipatory pleasure predicts motivation for
reward in major depression. J. Abnorm. Psychol. 121 (1), 51–60.
Simon, J.J., Biller, A., Walther, S., Roesch-Ely, D., Stippich, C., Weisbrod, M., Kaiser, S., 2010.
Neural correlates of reward processing in schizophrenia–relationship to apathy and
depression. Schizophr. Res. 118 (1-3), 154–161 (Epub 2009 Dec 2016).
Snaith, R.P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D., Trigwell, P., 1995. A
scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br.
J. Psychiatry 167 (1), 99–103.
Spitzer, R.L., Endicott, J., Robins, E., 1978. Research diagnostic criteria: rationale and reli-
ability. Arch. Gen. Psychiatry 35 (6), 773–782.
Stevens, A., Schwarz, J., Schwarz, B., Ruf, I., Kolter, T., Czekalla, J., 2002. Implicit and explicit
learning in schizophrenics treatedwith olanzapine and with classic neuroleptics. Psy-
chopharmacology (Berl.) 160 (3), 299–306 (Epub 2002 Feb 2007).
Strauss, G.P., Frank, M.J., Waltz, J.A., Kasanova, Z., Herbener, E.S., Gold, J.M., 2011a. Deﬁcits
in Positive Reinforcement Learning and Uncertainty-Driven Exploration Are Associat-
ed with Distinct Aspects of Negative Symptoms in Schizophrenia. Biol. Psychiatry 69
(5), 424–431.
Strauss, G.P., Gold, J.M., 2012. A new perspective on anhedonia in schizophrenia. Am.
J. Psychiatry 169 (4), 364–373.
Strauss, G.P., Herbener, E.S., 2011. Patterns of emotional experience in schizophrenia: dif-
ferences in emotional response to visual stimuli are associated with clinical presenta-
tion and functional outcome. Schizophr. Res. 128 (1-3), 117–123 (Epub 2011 Feb
2018).
Strauss, G.P., Morra, L.F., Sullivan, S.K., Gold, J.M., 2014. The Role of Low Cognitive Effort
and Negative Symptoms in Neuropsychological Impairment in Schizophrenia.
Neuropsychology.
Strauss, G.P., Waltz, J.A., Gold, J.M., 2013. A Review of Reward Processing andMotivational
Impairment in Schizophrenia. Schizophr. Bull.
Strauss, G.P., Wilbur, R.C., Warren, K.R., August, S.M., Gold, J.M., 2011b. Anticipatory vs.
consummatory pleasure: what is the nature of hedonic deﬁcits in schizophrenia?
Psychiatry Res. 187 (1-2), 36–41 (Epub 2011 Feb 2015).
Suslow, T., Junghanns, K., Weitzsch, C., Arolt, V., 1998. Relations between neuropsycholog-
ical vulnerability markers and negative symptoms in schizophrenia. Psychopathology
31 (4), 178–187.
Szendi, I., Kiss, M., Racsmany, M., Boda, K., Cimmer, C., Voros, E., Kovacs, Z.A., Szekeres, G.,
Galsi, G., Pleh, C., Csernay, L., Janka, Z., 2006. Correlations between clinical symptoms,
working memory functions and structural brain abnormalities in men with schizo-
phrenia. Psychiatry Res. 147( (1), 47–55 (Epub 2006 Mar 2020).
Tarrier, N., 2010. Broad Minded Affective Coping (BMAC): A “Positive” CBT Approach to
Facilitating Positive Emotions. Int. J. Cogn. Ther. 3 (1), 64–76.
Trémeau, F., Antonius, D., Cacioppo, J.T., Ziwich, R., Butler, P., Malaspina, D., Javitt, D.C.,
2010. Anticipated, on-line and remembered positive experience in schizophrenia.
Schizophr. Res. 122 (1-3), 199–205 (Epub 2009 Nov 2010).
Trémeau, F., Antonius, D., Cacioppo, J.T., Ziwich, R., Jalbrzikowski, M., Saccente, E., Silipo,
G., Butler, P., Javitt, D., 2009. In support of Bleuler: objective evidence for increased af-
fective ambivalence in schizophrenia based upon evocative testing. Schizophr. Res.
107 (2-3), 223–231 (Epub 2008 Oct 2022).
Trémeau, F., Antonius, D., Nolan, K., Butler, P., Javitt, D.C., 2014. Immediate affective moti-
vation is not impaired in schizophrenia. Schizophr. Res. (0).
Turkington, D., Kingdon, D., Weiden, P.J., 2006. Cognitive behavior therapy for schizophre-
nia. Am. J. Psychiatry 163 (3), 365–373.
Ursu, S., Kring, A.M., Gard, M.G., Minzenberg, M.J., Yoon, J.H., Ragland, J.D., Solomon,
M., Carter, C.S., 2011. Prefrontal cortical deﬁcits and impaired cognition-emotion
interactions in schizophrenia. Am. J. Psychiatry 168 (3), 276–285 (Epub 2011 Jan
2014).
Velthorst, E., Nieman, D.H., Becker, H.E., van de Fliert, R., Dingemans, P.M., Klaassen, R., de
Haan, L., van Amelsvoort, T., Linszen, D.H., 2009. Baseline differences in clinical
144 C.J. Edwards et al. / Schizophrenia Research 168 (2015) 120–144symptomatology between ultra high risk subjects with and without a transition to
psychosis. Schizophr. Res. 109 (1-3), 60–65 (Epub 2009 Mar 2009).
Walter, H., Heckers, S., Kassubek, J., Erk, S., Frasch, K., Abler, B., 2010. Further evidence for
aberrant prefrontal salience coding in schizophrenia. Front. Behav. Neurosci. 3, 62.
Walter, H., Kammerer, H., Frasch, K., Spitzer, M., Abler, B., 2009. Altered reward functions
in patients on atypical antipsychotic medication in line with the revised dopamine
hypothesis of schizophrenia. Psychopharmacology (Berl.) 206 (1), 121–132 (Epub
2009 Jun 2012).
Waltz, J.A., Brown, J.K., Gold, J.M., Ross, T.J., Salmeron, B.J., Stein, E.A., 2015. Probing the Dy-
namic Updating of Value in Schizophrenia Using a Sensory-Speciﬁc Satiety Paradigm.
Schizophr. Bull.
Waltz, J.A., Gold, J.M., 2007. Probabilistic reversal learning impairments in schizophrenia:
further evidence of orbitofrontal dysfunction. Schizophr. Res. 93( (1-3), 296–303
(Epub 2007 May 2007).
Waltz, J.A., Schweitzer, J.B., Gold, J.M., Kurup, P.K., Ross, T.J., Salmeron, B.J., Rose, E.J.,
McClure, S.M., Stein, E.A., 2009. Patients with schizophrenia have a reduced neural
response to both unpredictable and predictable primary reinforcers.
Neuropsychopharmacology 34 (6), 1567–1577 (Epub 2008 Dec 1563).
Waltz, J.A., Schweitzer, J.B., Ross, T.J., Kurup, P.K., Salmeron, B.J., Rose, E.J., Gold, J.M., Stein,
E.A., 2010. Abnormal responses to monetary outcomes in cortex, but not in the basal
ganglia, in schizophrenia. Neuropsychopharmacology 35 (12), 2427–2439 (Epub
2010 Aug 2418).Wang, C.S., Yang, Y.K., Chen, M., Chiu, N.T., Yeh, T.L., Lee, I.H., 2003. Negative symptoms
and regional cerebral blood ﬂow in patients with schizophrenia: a single photon
emission computed tomography study. Kaohsiung J. Med. Sci. 19 (9), 464–469.
Woodruff, P.W., Phillips, M.L., Rushe, T., Wright, I.C., Murray, R.M., David, A.S., 1997. Cor-
pus callosum size and inter-hemispheric function in schizophrenia. Schizophr. Res.
23 (3), 189–196.
World Health Organisation, 1992. ICD-10 Classiﬁcations of Mental and Behavioural Disor-
der: Clinical Descriptions and Diagnostic Guidelines. World Health Organisation,
Geneva.
Wykes, T., Huddy, V., Cellard, C., McGurk, S.R., Czobor, P., 2011. A meta-analysis of cogni-
tive remediation for schizophrenia: methodology and effect sizes. Am. J. Psychiatr.
168 (5), 472–485.
Wykes, T., Reeder, C., Landau, S., Everitt, B., Knapp, M., Patel, A., Romeo, R., 2007. Cognitive
remediation therapy in schizophrenia: Randomised controlled trial. Br. J. Psychiatry
190 (5), 421–427.
Wynn, J.K., Horan, W.P., Kring, A.M., Simons, R.F., Green, M.F., 2010. Impaired anticipatory
event-related potentials in schizophrenia. Int. J. Psychophysiol. 77 (2), 141–149
(Epub 2010 Jun 2014).
Yan, C., Cao, Y., Zhang, Y., Song, L.L., Cheung, E.F., Chan, R.C., 2012. Trait and state positive
emotional experience in schizophrenia: a meta-analysis. PLoS One 7 (7), e40672
(Epub 42012 Jul 40618).
